JOHN WILEY SONS INC
For the period ended Apr 30, 2025. Filed Jun 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jun 25, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Note
Note 3— Revenue Recognition, Contracts with Customers
Disaggregation of Revenue
The following tables present our revenue from contracts with customers disaggregated by segment and product type.
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Research: | |||
| Research Publishing | $922,553 | $892,784 | $926,773 |
| Research Solutions | 152,906 | 149,921 | 153,538 |
| Total Research | 1,075,459 | 1,042,705 | 1,080,311 |
| Learning: | |||
| Academic | 333,693 | 323,541 | 304,633 |
| Professional | 251,075 | 251,198 | 241,762 |
| Total Learning | 584,768 | 574,739 | 546,395 |
| Held for Sale or Sold | 17,382 | 255,543 | 393,194 |
| Total Revenue | $1,677,609 | $1,872,987 | $2,019,900 |
The following information describes our disaggregation of revenue by segment and product type. Overall, the majority of our revenue is recognized over time.
Research
Total Research revenue was $1,075.5 million in the year ended April 30, 2025. Research products are sold and distributed globally through multiple channels. The majority of revenue generated from Research products is recognized over time.
We disaggregated revenue by Research Publishing and Research Solutions to reflect the different types of products and services provided.
Research Publishing Products
Research Publishing products provide scientific, technical, medical, and scholarly journals, as well as related content and services, to academic, corporate, and government libraries, learned societies, and individual researchers and other professionals. Research Publishing revenue was $922.6 million in the year ended April 30, 2025, and the majority is recognized over time.
In the year ended April 30, 2025, Research Publishing products generated approximately 87% of its revenue from contracts with its customers from Journal Subscriptions (pay to read) and Transformational Agreements (read and publish) under multiyear arrangements, and Open Access (pay to publish). The remaining revenue is from Licensing and ancillary products.
Journal Subscriptions and Transformational Models
Journal Subscription contracts are negotiated by us directly with customers or their subscription agents. Subscription periods typically cover calendar years. In a typical Journal Subscription sale, there is a written agreement between us and our customer that covers multiple years. However, we typically account for these agreements as one-year contracts because our enforceable rights under the agreements are subject to an annual confirmation and negotiation process with the customer.
Index
In Journal Subscriptions, there are generallytwo performance obligations: a functional intellectual property license with a stand-ready obligation to provide access to new content forone year, which includes online hosting of the content (collectively referred to as Read) which is recognized over time, and a functional intellectual property perpetual license for access to historical journal content (Perpetual License) which is recognized at the point in time when access to the historical content is initially granted. The transaction price consists of fixed consideration. Journal Subscription revenue is generally collected in advance when the annual license is granted.
The total transaction price is allocated to each performance obligation based on its relative standalone selling price using a combination of observable and estimated stand-alone selling prices, which includes the expected cost plus a margin approach. We allocate revenue to the stand-ready obligation to provide access to new content forone year based on its observable standalone selling price to provide the right of access to additional intellectual property. The allocation of revenue to the perpetual licenses for access to historical journal content is done using the expected cost plus a margin approach, as applicable.
Transformational Agreements (read and publish) blend Journal Subscription and Open Access offerings. Generally, for a single fee, a national or regional consortium of libraries pays for and receives full read access to our journal portfolio and the ability to publish under an open access arrangement. Transformational Agreements include multiple performance obligations and depending upon the model, can include a combination of Read which is recognized over time; Perpetual License which is recognized at a point in time; and a publishing right that allows for articles to be published in hybrid and/or gold open access journals, which is recognized point in time or over time depending upon the model. The total transaction price is generally fixed and allocated to each performance obligation based on its relative stand-alone selling price using a combination of observable and estimated stand-alone selling prices. Estimated stand-alone selling prices include the expected cost plus a margin approach, and a residual approach.
Open Access
Under the open access business model, there is generally one performance obligation whereby accepted research articles are published and all open articles are immediately free to access online. The transaction price is fixed based on payment of an article publication charge (APC). Revenue is recognized at a point in time which is upon publication which is when Wiley’s obligation is complete.
Licensing and Ancillary Products
Within licensing the revenue derived from these contracts is primarily comprised of advance payments, including minimum guarantees and sales- or usage-based royalty agreements. Our intellectual property is considered to be functional intellectual property. Due to the stand-ready obligation to provide updates during the subscription period, which is generally an annual period, revenue for the minimum guarantee is recognized on a straight-line basis over the term of the agreement. For our sales- or usage-based royalty agreements, we recognize revenue in the period of usage based on the amounts earned. We record revenue under these arrangements for the amounts due and not yet reported to us based on estimates of the sales or usage of these customers and pursuant to the terms of the contracts. We also have certain licenses whereby we receive a non-refundable minimum guarantee in advance (recorded over time as described above) against a volume-based royalty throughout the term of the agreement. When the cumulative consideration exceeds the minimum guarantee, it is recognized as the subsequent sales or usage occurs. We also license content for artificial intelligence (AI) models at a fixed transaction price and the majority of the revenue is recognized at a point in time which is upon acceptance.
Research Solutions Products and Services
Research Solutions revenue was $152.9 million in the year ended April 30, 2025, and the majority is recognized over time.
In the year ended April 30, 2025, Research Solutions products and services generated approximately 55% of their revenue from contracts with customers that include corporate solutions such as managed services which includes advertising, and full sales and marketing services for publishers and societies; recruitment platform and services; spectral databases; and projects which includes content creation and distribution, digital events, and webinars.
Index
The remainder of the revenue within Research Solutions from contracts with customers includes platform and workflow solutions for societies and publishers, which includes production and content hosting, submissions and peer review support, editorial, and copy editing services. Included within platforms is our Atypon® publishing platform for societies and publishers which includes a single performance obligation for the implementation and hosting of subscription services. The transaction price is fixed which may include price escalators that are fixed increases per year. Revenue is recognized upon the initiation of the subscription period and recognized on a straight-line basis over the time of the contractual period. The duration of these contracts is generally multiyear ranging from 2 to 5 years.
Learning
Total Learning revenue was $584.8 million in the year ended April 30, 2025. We disaggregated revenue by Academic and Professional to reflect the different types of products and services provided.
Academic
Academic products revenue was $333.7 million in the year ended April 30, 2025. Products and services include scientific, professional, and education print and digital books, and digital courseware to libraries, corporations, students, professionals, and researchers. Products are developed for worldwide distribution through multiple channels, including chain and online booksellers, libraries, colleges and universities, corporations, direct to consumer, websites, distributor networks and other online applications.
In the year ended April 30, 2025, Academic products generated approximately 54% of their revenue from contracts with their customers for print and digital publishing, which is recognized at a point in time. Digital Courseware products generate approximately 33% of their revenue from contracts with their customers which is recognized over time. The remainder of their revenues were from Licensing and ancillary products which have a mix of revenue recognized at a point in time and over time.
Print and Digital Publishing
Our performance obligations as they relate to print and digital publishing are primarily book products delivered in both print and digital form which could include single or multiple performance obligations based on the number of print or digital books purchased. Each is represented by an International Standard Book Number (ISBN), with each ISBN representing a performance obligation. Each ISBN has an observable stand-alone selling price as Wiley sells the books separately. This revenue stream also includes variable consideration as it relates to returns for both print and digital books. Revenue is recognized at the point when control of the product transfers, which for print is upon shipment or for digital when fulfillment of the products has been rendered.
Digital Courseware Products
Courseware customers purchase access codes to utilize the product. Revenue is recognized over time in the period from when the access codes are activated over the applicable semester term to which such product relates.
Licensing and Ancillary Products
Revenue derived from our licensing contracts is primarily comprised of advance payments and sales- or usage-based royalties. Revenue for advance payments is recognized at the point in time that the functional intellectual property license is granted. For sales- or usage-based royalties, we record revenue under these arrangements for the amounts due and not yet reported to us based on estimates of the sales or usage of these customers and pursuant to the terms of the contracts. We also have certain licenses whereby we receive a non-refundable minimum guarantee (recognized at a point in time as described above) against a volume-based royalty throughout the term of the agreement. We recognize volume-based royalty income only when cumulative consideration exceeds the minimum guarantee and the subsequent sales or usage occurs. We also license content for AI models at a fixed transaction price and the revenue is recognized at a point in time which is upon acceptance.
Index
Professional
Professional products revenue was $251.1 million in the year ended April 30, 2025. Professional provides learning, development, publishing, and assessment services for businesses and professionals. Our professional publishing produces books, which includes business and finance, technology, professional development for educators, test preparation books and other professional categories, as well as the For Dummies® brand. Products are sold to brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, and government agencies.
In the year ended April 30, 2025, Professional products generated approximately 55% of their revenue from contracts with their customers for professional publishing, which is recognized at a point in time. Our assessments offering in the year ended April 30, 2025 generates approximately 30% of their revenue from contracts with its customers, which has a mix of revenue recognized at a point in time and over time. The remainder of Professional revenues were from Licensing and ancillary revenue streams, which has a mix of revenue recognized at a point in time and over time.
Professional Publishing
Professional publishing has the same performance obligations as Academic print and digital publishing which is described above. Revenue is recognized at the point when control of the product transfers, which for print is upon shipment or for digital when fulfillment of the products has been rendered.
Assessments
Our assessments offering includes high-demand soft-skills training solutions that are delivered to organizational clients through online digital delivery platforms, either directly or through an authorized distributor network of independent consultants, trainers, and coaches. Our assessments product offering includes multiple performance obligations which includes annual memberships which are recognized over time, and the assessments and related products or services which are recognized at a point in time. We allocate revenue based on observable standalone selling prices of each performance obligation.
Revenue derived from our licensing contracts is primarily comprised of advance payments and sales- or usage-based royalties. Revenue for advance payments is recognized at the point in time that the functional intellectual property license is granted. For sales- or usage-based royalties, we record revenue under these arrangements for the amounts due and not yet reported to us based on estimates of the sales or usage of these customers and pursuant to the terms of the contracts. We also have certain licenses whereby we receive a non-refundable minimum guarantee (recognized at a point in time as described above) against a volume-based royalty throughout the term of the agreement. We recognize volume-based royalty income only when cumulative consideration exceeds the minimum guarantee and the subsequent sales or usage occurs. We also license our content for AI model training and development as described above.
Held for Sale or Sold
Held for Sale or Sold revenue was $17.4 million in the year ended April 30, 2025.
Wiley Edge was sold on May 31, 2024 with exception of its India operations which sold on August 31, 2024. Wiley Edge previously sourced, trained, and prepared aspiring students and professionals to meet the skill needs of today’s technology careers, and then place them with some of the world’s largest financial institutions, technology companies, and government agencies. Wiley Edge revenue was recognized at the point in time the services were provided to its customers.
CrossKnowledge was sold on August 31, 2024. CrossKnowledge services previously included corporate learning online learning and training solutions for global corporations, universities, and small and medium-sized enterprises sold on a subscription or fee basis. CrossKnowledge revenue was recognized over time.
Held for Sale or Sold also includes the revenue associated with those businesses which were sold in fiscal year 2024 which includes University Services and Tuition Manager, and in fiscal year 2023 includes Wiley’s Efficient Learning test prep portfolio business, and our advancement courses business.
Index
Accounts Receivable, Net and Contract Liability Balances
When consideration is received, or such consideration is unconditionally due, from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded. Contract liabilities are recognized as revenue when, or as, control of the products or services are transferred to the customer and all revenue recognition criteria have been met.
The following table provides information about accounts receivable, net and contract liabilities from contracts with customers.
| April 30, 2025 | April 30, 2024 | Increase/(Decrease) | |
|---|---|---|---|
| Balances from contracts with customers: | |||
| Accounts receivable, net | $228,410 | $224,198 | $4,212 |
| Contract liabilities(1) | 462,693 | 483,778 | (21,085) |
| Contract liabilities (included in Other long-term liabilities) | $16,725 | $14,819 | $1,906 |
| (1) | The sales return reserve recorded in Contract liabilities is $15.1 million and $25.4 million as of April 30, 2025 and April 30, 2024, respectively. See Note 2, “Summary of Significant Accounting Policies, Recently Issued, and Recently Adopted Accounting Standards” for further details of the sales return reserve. |
For the years ended April 30, 2025 and 2024, we recognized as revenue substantially all of the current contract liability balance at April 30, 2024 and 2023, respectively.
The decrease in contract liabilities, excluding the sales return reserve, was primarily driven by revenue earned on journal subscription agreements, transformational agreements, and open access, partially offset by renewals of journal subscription agreements, transformational agreements, and open access.
Remaining Performance Obligations included in Contract Liability
As of April 30, 2025, the aggregate amount of the transaction price allocated to the remaining performance obligations is approximately $479.4 million, which includes the sales return reserve of $15.1 million. Excluding the sales return reserve, we expect that approximately $447.6 million will be recognized in the next twelve months with the remaining $16.7 million to be recognized thereafter.
Assets Recognized for the Costs to Fulfill a Contract
Costs to fulfill a contract are directly related to a contract that will be used to satisfy a performance obligation in the future and are expected to be recovered. These costs are amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. These types of costs are incurred in Research Solutions services which includes customer specific implementation costs per the terms of the contract.
Our assets associated with incremental costs to fulfill a contract were $2.2 million and $3.1 million at April 30, 2025 and 2024, respectively, and are included within Other non-current assets on our Consolidated Statements of Financial Position.
We recorded amortization expense related to these assets within Cost of sales on the Consolidated Statements of Income (Loss) as follows:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Amortization expense | $1,385 | $4,527 | $4,465 |
In the years ended April 30, 2024 and 2023 amortization expense for costs to fulfill includes the amortization related to the University Services business which was sold on January 1, 2024.
Index
Sales and value-added taxes are excluded from revenues. Shipping and handling costs, which are primarily incurred within the Learning segment, occur before the transfer of control of the related goods. Therefore, in accordance with the revenue standard, it is not considered a promised service to the customer and would be considered a cost to fulfill our promise to transfer the goods. Costs incurred for third-party shipping and handling are primarily reflected in Operating and administrative expenses on the Consolidated Statements of Income (Loss) and were incurred as follows:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Shipping and handling costs | $23,644 | $25,853 | $27,149 |
Note 4 –Acquisitions and Divestitures
Acquisitions
Pro forma financial information related to this acquisition has not been provided as it is not material to our consolidated results of operations.
On February 3, 2025, we completed the acquisition of an immaterial business included in our Learning segment. The allocation of the total consideration transferred to the assets acquired, including intangible assets and goodwill, and the liabilities assumed will be finalized within the measurement period, which will not exceed one year from the acquisition date.
Divestitures
On June 1, 2023, Wiley’s Board of Directors approved a plan to divest certain businesses that we determined are non-core businesses. Those businesses are University Services, Wiley Edge, and CrossKnowledge. As of the second quarter of fiscal year 2025, we completed our plan to divest these businesses.
On January 1, 2024, we sold University Services. On May 31, 2024, we sold Wiley Edge, with the exception of its India operations, which sold on August 31, 2024. On August 31, 2024, we also sold CrossKnowledge.
In accordance with FASB ASC Topic 205, “Presentation of Financial Statements,” we determined that the divestitures of University Services, Wiley Edge and CrossKnowledge each do not represent a strategic shift that will have a major effect on our consolidated results of operations, and therefore their results of operations were not reported as discontinued operations. We concluded that the businesses met all the requisite held-for-sale criteria as of June 1, 2023. Therefore, the related assets and liabilities were reclassified as held-for-sale on the Consolidated Statements of Financial Position until the date of sale.
For the years ended April 30, 2025, 2024, and 2023, we recorded net pretax (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale as follows:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| CrossKnowledge | $4,119 | $(55,440) | $— |
| Wiley Edge | (14,852) | (19,401) | — |
| University Services | (12,578) | (107,048) | — |
| Tuition Manager | 120 | (1,500) | — |
| Test Prep and Advancement Courses | — | — | 10,177 |
| Sale of assets | (149) | — | — |
| Net (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale | $(23,340) | $(183,389) | $10,177 |
Index
These charges are reflected in Net (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale on our Consolidated Statements of Income (Loss).
CrossKnowledge
On August 31, 2024, we completed the sale of CrossKnowledge, which was included in our Held for Sale or Sold segment, pursuant to a stock and asset purchase agreement (CrossKnowledge Agreement) with MS International Software, LLC, a Delaware limited liability company (MS International). The selling price for CrossKnowledge, which was subsequently updated during the year ended April 30, 2025, had an estimated fair value of $3.0 million.
The pretax loss on sale was $51.3 million after accounting for the assets sold, liabilities transferred upon sale, transaction costs, and the write-off of cumulative translation adjustments in earnings. In connection with the held-for-sale classification prior to the sale, we recognized cumulative impairment charges of $51.0 million on the remeasurement of the disposal group at the lower of carrying value or fair value less costs to sell, which included $55.4 million recognized in fiscal year 2024. Upon the completion of the sale, we recognized a net gain of $4.1 million in the year ended April 30, 2025 primarily due to subsequent changes in the fair value less costs to sell, as well as changes in the carrying amount of the disposal group.
We entered into a transition services agreement to facilitate the transition of the divested business.
Wiley Edge
On May 31, 2024, we completed the sale of Wiley Edge with the exception of its India operations which sold on August 31, 2024, which was included in our Held for Sale or Sold segment, pursuant to a stock and asset purchase agreement (Edge Agreement) with Inspirit Vulcan Bidco Limited, a private limited company incorporated in England & Wales (Inspirit). The selling price for Wiley Edge at the date of sale including India, which was subsequently updated during the year ended April 30, 2025, had a fair value of $23.3 million paid in the form of: (i) cash of $10.0 million, (ii) an unsecured promissory note with an aggregate principal amount of $13.3 million (Inspirit Seller Note), which was subject to customary working capital adjustments, and (iii) additional contingent consideration in the form of an earnout recorded at a fair value ofzero based on the gross profit targets during each of the three fiscal years in the period beginning May 1, 2024 and ending April 30, 2027 (Wiley Edge Earnout).
As of April 30, 2025, the Inspirit Seller Note is reflected in Other non-current assets in our Consolidated Statements of Financial Position. The Inspirit Seller Note matures on May 31, 2028 and is prepayable at par plus accrued interest at any time and also if certain conditions are met. The Inspirit Seller Note bears interest at the rate of 8% per annum commencing on May 31, 2024, increasing by 1% per annum each year on the anniversary of issuance. Interest income from the note receivable represents non operating income and is included in Other income (expense), net on the Consolidated Statements of Income (Loss).
The maximum Wiley Edge Earnout amount is $34.0 million. We elected to record the fair value of the Wiley Edge Earnout as of the date of the sale, and will update that fair value as applicable until settled since the Wiley Edge Earnout amount is subject to change based on final results and calculations. The fair value of the Wiley Edge Earnout at the date of the sale was based on a Monte Carlo simulation and was initially valued at $15.0 million. Due to changes in market conditions during the third quarter of fiscal year 2025 that negatively impacted placements and the outlook for the business, the updated gross profit forecast indicated that the gross profit for each of the earnout periods will be below the gross profit targets as defined in the Edge Agreement which would result in zero amount being paid to Wiley in each of the respective periods. As a result, in the third quarter of fiscal year 2025 we reduced the fair value of the Wiley Edge Earnout from $15.0 million at the date of sale tozero.
The pretax loss on sale was $34.3 million after accounting for the assets sold, liabilities transferred upon sale, transaction costs, and the write-off of cumulative translation adjustments in earnings. In connection with the held-for-sale classification, during fiscal year 2024, we recognized cumulative impairment charges of $19.4 million on the remeasurement of the disposal group at the lower of carrying value or fair value less costs to sell. Upon the completion of the sale, we recognized a net loss of $14.9 million in the year ended April 30, 2025 primarily due to subsequent changes in the fair value less costs to sell, partially offset by the sale of the India operations.
Index
We entered into a transition services agreement to facilitate the transition of the divested business.
Fiscal Year 2024
University Services
On January 1, 2024, we completed the sale of University Services, which was included in our Held for Sale or Sold segment, pursuant to a Membership Interest and Asset Purchase Agreement (University Services Agreement) with Academic Partnerships LLC, a Delaware limited liability company (Academic Partnerships), and Education Services Upper Holdings Corp., a Delaware corporation (Upper Holdings). The pretax loss on sale as of April 30, 2024 was $107.0 million, after accounting for the assets sold, liabilities transferred upon sale, and transaction costs.
The selling price for University Services included (i) an unsecured promissory note (University Services Seller Note); (ii) additional contingent consideration in the form of an earnout recorded at fair value based on revenue targets during each of the two fiscal years in the period from May 1, 2024 through April 30, 2026 (University Services Earnout); and (iii) a number of common units of TVG-Academic Partnerships Holdings, LLC, the ultimate parent company of Academic Partnerships equal to 10% of the total common units outstanding accounted for under the cost method minus impairment (TVG Investment).
As of April 30, 2025 in our Consolidated Statements of Financial Position, the aggregate amounts reflected in Other non-current assets for the principal and interest amount of the University Services Seller Note, the TVG Investment, and the long-term portion of the University Services Earnout was $110.0 million. In addition, the short-term portion of the University Services Earnout was $9.5 million reflected in Prepaid expenses and other current assets.
On June 5, 2025, Wiley entered into an agreement with Metis Aggregator L.P. and Vistria AP Aggregator, LLCto sell the Seller Note, the fiscal year 2026 University Services Earnout, and the TVG Investment, and agreed with Upper Holdings and Academic Partnerships on the fiscal year 2025 University Services Earnout for total cash consideration of $119.5 million (Sale Agreement) which was fully paid in June 2025. As a result of this Sale Agreement, all amounts due to Wiley in accordance with the University Services Agreement have been settled.
In the year ended April 30, 2025, due to the process of selling these assets, as well as third-party customer consents, working capital adjustments, and changes in the costs to sell, we recognized an additional net loss on sale and impairments of assets of $12.6 million.
Tuition Manager
On May 31, 2023, we completed the sale of our tuition manager business (Tuition Manager), which was included in our Held for Sale or Sold segment, for a pretax loss on sale of $1.4 million, of which $1.5 million was recognized in the year ended April 30, 2024 and a gain of $0.1 million was recognized in the year ended April 30, 2025 due to additional cash received.
Fiscal Year 2023
Test Prep and Advancement Courses
On February 28, 2023, we completed the sale of Wiley’s Efficient Learning test prep portfolio business. In addition, on March 31, 2023, we completed the sale of our advancement courses business. Both were included in our Held for Sale or Sold segment. Neither disposition constituted a strategic shift, and the impact on our overall operations and financial results was not material. Accordingly, the operations associated with the dispositions are not reported in discontinued operations. The selling price for both dispositions was $16.5 million, which included $15.5 million of cash received net of transaction costs at the date of sale, and $1.0 million of additional cash received after the date of sale. The pretax gain on sale was $10.2 million, after accounting for the assets sold, liabilities transferred upon sale, and transaction costs.
Index
Assets and Liabilities Held-for-Sale
There are no assets or liabilities held-for-sale as of April 30, 2025. The major categories of assets and liabilities that have been classified as held-for-sale on the Consolidated Statement of Financial Position as of April 30, 2024 were as follows:
| Cross Knowledge | Wiley Edge | Total | |
|---|---|---|---|
| Assets held-for-sale: | |||
| Current assets | |||
| Cash and cash equivalents (1) | $6,305 | $9,887 | $16,192 |
| Accounts receivable, net | 12,914 | 13,897 | 26,811 |
| Prepaid expenses and other current assets (1) | 3,780 | 5,548 | 9,328 |
| Valuation allowance | (17,909) | — | (17,909) |
| Total current assets held-for-sale | $5,090 | $29,332 | $34,422 |
| Technology, property and equipment, net | 3,786 | 2,888 | 6,674 |
| Intangible assets, net | 17,777 | 34,612 | 52,389 |
| Operating lease right-of-use assets | 1,091 | 1,008 | 2,099 |
| Other non-current assets | 14,877 | 53 | 14,930 |
| Valuation allowance | (37,531) | (19,401) | (56,932) |
| Total non-current assets held-for-sale | $— | $19,160 | $19,160 |
| Liabilities held-for-sale: | |||
| Current liabilities | |||
| Accounts payable | $494 | $— | $494 |
| Accrued royalties | 268 | — | 268 |
| Contract liabilities | 16,796 | — | 16,796 |
| Accrued employment costs | 7,805 | 3,990 | 11,795 |
| Short-term portion of operating lease liabilities | 319 | 468 | 787 |
| Other accrued liabilities | 2,762 | 4,730 | 7,492 |
| Total current liabilities held-for-sale | $28,444 | $9,188 | $37,632 |
| Accrued pension liability | 1,037 | — | 1,037 |
| Deferred income tax liabilities | 4,420 | 4,448 | 8,868 |
| Operating lease liabilities | 251 | 159 | 410 |
| Other long-term liabilities | 694 | 228 | 922 |
| Total long-term liabilities held-for-sale | $6,402 | $4,835 | $11,237 |
| (1) | The following table shows a reconciliation of our cash, cash equivalents, and restricted cash included in current assets held-for-sale in our Consolidated Statement of Financial Position to our Consolidated Statement of Cash Flows for the year ended April 30, 2024: |
Index
| Cash and cash equivalents | $83,249 |
|---|---|
| Restricted cash included in Prepaid expenses and other current assets | 50 |
| Total cash, cash equivalents, and restricted cash per Consolidated Statement of Financial Position as of April 30, 2024 | 83,299 |
| Cash and cash equivalents held-for-sale | 16,192 |
| Restricted cash held-for-sale included in Prepaid expenses and other current assets | 52 |
| Total cash, cash equivalents, and restricted cash held-for-sale as of April 30, 2024 | 16,244 |
| Total cash, cash equivalents, and restricted cash per Consolidated Statement of Cash Flows for the year ended April 30, 2024 | $99,543 |
Sale of Assets
In the second quarter of fiscal year 2025, we sold a facility which was reflected in Technology, property, and equipment, net in our Consolidated Statements of Financial Position which resulted in a pretax loss on sale of $0.2 million, and we received net cash of $8.5 million.
Note 5 –Reconciliation of Weighted Average Shares Outstanding
Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share further includes any common shares available to be issued upon the exercise of unvested, outstanding restricted stock units and other stock awards if such inclusions would be dilutive. The shares associated with performance-based stock awards (PSU) are considered contingently issuable shares and are included in the diluted weighted average number of common shares outstanding based on when they have met the performance conditions, and when their effect is dilutive. We determine the potentially dilutive common shares for all awards using the treasury stock method.
A reconciliation of the shares used in the computation of earnings (loss) per share follows (shares in thousands):
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Weighted average shares outstanding | 54,054 | 54,945 | 55,558 |
| Shares used for basic earnings (loss) per share | 54,054 | 54,945 | 55,558 |
| Dilutive effect of unvested restricted stock units and other stock awards | 776 | — | 797 |
| Shares used for diluted earnings (loss) per share | 54,830 | 54,945 | 56,355 |
| Antidilutive options to purchase Class A common shares, restricted shares, and contingently issuable restricted stock which are excluded from the table above | 509 | 1,264 | 393 |
In calculating diluted net loss per common share for the year ended April 30, 2024, our diluted weighted average number of common shares outstanding excludes the effect of unvested restricted stock units and other stock awards as the effect was anti-dilutive. This occurs when a net loss is reported and the effect of using dilutive shares is antidilutive.
Index
Note 6 –Accumulated Other Comprehensive Loss
Changes in Accumulated other comprehensive loss by component, net of tax, for the years ended April 30, 2025, 2024, and 2023 were as follows:
| ForeignCurrencyTranslation | UnamortizedRetirementCosts | InterestRate Swaps | Total | |
|---|---|---|---|---|
| Balance at April 30, 2022 | $(329,566) | $(182,226) | $3,646 | $(508,146) |
| Other comprehensive income (loss) before reclassifications | 3,220 | (29,053) | 4,385 | (21,448) |
| Amounts reclassified from Accumulated other comprehensive loss | — | 4,473 | (3,781) | 692 |
| Total other comprehensive income (loss) | 3,220 | (24,580) | 604 | (20,756) |
| Balance at April 30, 2023 | $(326,346) | $(206,806) | $4,250 | $(528,902) |
| Other comprehensive (loss) income before reclassifications | (7,481) | (37) | 11,398 | 3,880 |
| Amounts reclassified from Accumulated other comprehensive loss | — | 5,921 | (9,338) | (3,417) |
| Total other comprehensive (loss) income | (7,481) | 5,884 | 2,060 | 463 |
| Balance at April 30, 2024 | $(333,827) | $(200,922) | $6,310 | $(528,439) |
| Other comprehensive income (loss) before reclassifications | 46,052 | (14,370) | (7,912) | 23,770 |
| Amounts reclassified from Accumulated other comprehensive loss | 23,227 | 6,102 | (3,580) | 25,749 |
| Total other comprehensive income (loss) | 69,279 | (8,268) | (11,492) | 49,519 |
| Balance at April 30, 2025 | $(264,548) | $(209,190) | $(5,182) | $(478,920) |
In connection with the sale of Wiley Edge and CrossKnowledge, in the year ended April 30, 2025, we reclassified $23.2 million of cumulative translation adjustments out of Accumulated other comprehensive loss and included in the Net (loss) gain on sale of businesses, assets, and impairment charges related to assets held-for-sale in our Consolidated Statements of Income (Loss).
For the years ended April 30, 2025, 2024, and 2023, pretax actuarial losses included in Unamortized Retirement Costs of approximately $8.1 million, $7.9 million, and $6.0 million, respectively, were amortized from Accumulated other comprehensive loss and recognized as pension and post-retirement benefit (expense) primarily in Operating and administrative expenses and Other income (expense), net on our Consolidated Statements of Income (Loss).
Our policy for releasing the income tax effects from accumulated other comprehensive (loss) income is to release when the corresponding pretax accumulated other comprehensive (loss) income items are reclassified to earnings.
Index
Note 7 –Restructuring and Related Charges
Global Restructuring Program
The Company began a global restructuring program in fiscal year 2023, which aimed to enhance Wiley’s position and drive profitability (Global Restructuring Program) which was expanded in fiscal year 2024. This program included severance related charges for the elimination of certain positions, the exit of certain leased office space, and the reduction of our occupancy at other facilities. Under this program, we reduced our real estate square footage occupancy by approximately 35%.
In the fourth quarter of fiscal year 2025, the program was further extended due to the completion of our divestitures with a focus on optimizing our cost structure, with particular emphasis on aligning our technology costs and other corporate expenses. As a result of these initiatives, this expanded program includes severance related charges, facility-related costs associated with certain properties, and other activities.
The following tables summarize the pretax restructuring charges related to the Global Restructuring Program:
| For the Years Ended April 30, · Total Charges Incurred to Date | ||||
|---|---|---|---|---|
| 2025 · 2024 · 2023 | ||||
| Charges (Credits) by Segment: | ||||
| Research | $10,047 | $7,410 | $2,413 | $19,870 |
| Learning | 1,515 | 11,448 | 7,804 | 20,767 |
| Held for Sale or Sold | (117) | 7,326 | 5,786 | 12,995 |
| Corporate expenses | 17,902 | 35,370 | 32,879 | 86,151 |
| Total Restructuring and Related Charges | $29,347 | $61,554 | $48,882 | $139,783 |
| Charges by Activity: | ||||
| Severance and termination benefits | $20,596 | $28,556 | $25,827 | $74,979 |
| Impairment of operating lease ROU assets and technology, property and equipment | 656 | 10,043 | 12,696 | 23,395 |
| Acceleration of expense related to operating lease ROU assets, technology, property and equipment, and intangible assets | 1,786 | 4,148 | 2,140 | 8,074 |
| Facility related charges, net | 4,249 | 4,254 | 4,150 | 12,653 |
| Consulting costs | 657 | 8,967 | 2,285 | 11,909 |
| Other activities | 1,403 | 5,586 | 1,784 | 8,773 |
| Total Restructuring and Related Charges | $29,347 | $61,554 | $48,882 | $139,783 |
The severance related charges are for certain employees affected by the reduction in force under this program who are entitled to severance payments and certain termination benefits.
In the years ended April 30, 2024 and 2023, the impairment charges include the impairment of operating lease ROU assets related to certain leases that will be subleased, and the related property and equipment described further below. In the year ended April 30, 2024, these charges were recorded in Corporate Expenses and the Research segment. In the year ended April 30, 2023, these charges were recorded in Corporate Expenses.
Index
Due to the actions taken above, we tested the operating lease ROU assets and the related property and equipment for those being subleased for recoverability by comparing the carrying value of the asset group to an estimate of the future undiscounted cash flows expected to result from the use and eventual disposition of the asset group. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset groups were below the carrying values. Therefore, there was an indication of impairment. We then determined the fair value of the asset groups by utilizing the present value of the estimated future cash flows attributable to the assets. The fair value of these operating lease ROU assets and the property and equipment immediately subsequent to the impairment was $8.7 million and $12.1 million in the years ended April 30, 2024 and 2023, respectively, and were categorized as Level 3 within the FASB ASC Topic 820, “Fair Value Measurements” fair value hierarchy.
In addition, in the years ended April 30, 2025 and 2024, the impairment charges include the impairment of certain work-in-process capitalized software because it is no longer probable that the software being developed will be completed, and the work-in-process capitalized software was reported at the lower of its carrying amount or fair value which was zero. In the year ended April 30, 2025 these charges were recorded in the Research segment. In the year ended April 30, 2024, these charges were recorded in the Learning and Research segments, and in Corporate Expenses.
In the years ended April 30, 2024 and 2023, the acceleration of expense includes the acceleration of rent expense associated with operating lease ROU assets related to certain leases that will be abandoned or terminated, and the related depreciation and amortization of property and equipment. In addition, in the years ended April 30, 2025 and 2024, the acceleration of expense includes the acceleration of amortization expense of certain capitalized software as a result of our decision to discontinue the use of those assets. We determined that a revision of the useful lives was warranted, and certain capitalized software was fully amortized over its revised remaining useful life. The acceleration of expense in the year ended April 30, 2025 also includes the acceleration of amortization expense of an intangible asset in our Research segment due to a revision of the useful life which resulted in the asset being fully amortized over its revised remaining useful life.
We incurred ongoing facility-related costs associated with certain properties, consulting costs, and costs for other activities, which includes relocation and other employee related costs.
In fiscal year 2023, due to the political instability and military actions between Russia and Ukraine, we made the decision to close our operations in Russia which primarily consisted of technology development resources. We were substantially complete with our closure as of April 30, 2023, except for the formal liquidation of the Russian legal entity, which we completed in the fourth quarter of fiscal year 2025. Since we were substantially liquidated as of April 30, 2023, we wrote off $1.4 million, $1.0 million, and $1.1 million in the years ended April 30, 2025, 2024, and 2023, respectively, of cumulative translation adjustment gains in earnings. This is reflected in Net foreign exchange transaction (losses) gains in the Consolidated Statements of Income (Loss). Included in the table above arerestructuring charges for the years ended April 30, 2025, 2024, and 2023 of$0.9 million,$2.0 million and$8.3 million, respectively, related to these actions.
The following table summarizes the activity for the Global Restructuring Program liability for the year ended April 30, 2025:
| April 30, 2024 | Charges | Payments | ForeignTranslation& Other Adjustments | April 30, 2025 | |
|---|---|---|---|---|---|
| Severance and termination benefits | $5,396 | $20,596 | $(18,477) | $(893) | $6,622 |
| Consulting costs | 1,794 | 657 | (1,525) | 1 | 927 |
| Other activities | 1,879 | 1,403 | (2,331) | (662) | 289 |
| Total | $9,069 | $22,656 | $(22,333) | $(1,554) | $7,838 |
Approximately $5.6 million of the restructuring liability for accrued severance and termination benefits is reflectedin Accrued employment costs and approximately $1.0 million is reflected in Other long-term liabilities on our Consolidated Statements of Financial Position. The liability for consulting costs and other activities is reflected in Other accrued liabilities on our Consolidated Statements of Financial Position.
Index
Business Optimization Program
For the years ended April 30, 2025, 2024, and 2023, we recorded pretax restructuring (credits) charges of $(3.8) million, $1.4 million, and$0.5 million, respectively, related to this program. The net credits in the year ended April 30, 2025 are primarily due to the termination of a portion of a lease that was previously impaired in our Corporate Expenses category.
As of April 30, 2023, we substantially completed this program and we have no restructuring liability outstanding. We currently anticipate immaterial ongoing facility charges and do not anticipate any further material charges related to the Business Optimization Program.
Note 8 –Inventories
Inventories, net consisted of the following at April 30:
| 2025 | 2024 | |
|---|---|---|
| Finished goods | $27,581 | $24,295 |
| Work-in-process | 632 | 1,445 |
| Paper and other materials | 124 | 181 |
| Total inventories before estimated sales returns and LIFO reserve | 28,337 | 25,921 |
| Inventory value of estimated sales returns | 4,042 | 7,833 |
| LIFO reserve | (9,504) | (7,535) |
| Inventories, net | $22,875 | $26,219 |
See Note 2, “Summary of Significant Accounting Policies, Recently Issued and Recently Adopted Accounting Standards,” under the caption “Sales Return Reserves,” for a discussion of the Inventory value of estimated sales returns.
Finished goods are net of a reserve for inventory obsolescence of $11.1 million and $11.9 million as of April 30, 2025 and 2024, respectively.
Note 9 –Product Development Assets
Product development assets, net were included in Other non-current assets on the Consolidated Statements of Financial Position and consisted of the following at April 30:
| 2025 | 2024 | |
|---|---|---|
| Book composition costs | $247,442 | $213,811 |
| Software costs | 50,960 | 52,415 |
| Content development costs | 1,033 | 596 |
| Product development assets, gross | 299,435 | 266,822 |
| Accumulated amortization | (283,382) | (249,183) |
| Product development assets, net | $16,053 | $17,639 |
The following table details our amortization expense for product development assets, net:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Amortization expense | $16,610 | $22,835 | $32,366 |
Product development assets include $3.3 million and $2.3 million of work-in-process as of April 30, 2025 and 2024, respectively, primarily for book composition costs.
Index
Note 10 –Technology, Property, and Equipment
Technology, property, and equipment, net consisted of the following at April 30:
| 2025 | 2024 | |
|---|---|---|
| Capitalized software | $644,900 | $601,452 |
| Computer hardware | 54,160 | 53,918 |
| Buildings and leasehold improvements | 67,589 | 82,199 |
| Furniture, fixtures, and warehouse equipment | 31,817 | 31,814 |
| Land and land improvements | 860 | 3,283 |
| Technology, property, and equipment, gross | 799,326 | 772,666 |
| Accumulated depreciation and amortization | (637,201) | (580,228) |
| Technology, property, and equipment, net | $162,125 | $192,438 |
The following table details our depreciation and amortization expense for technology, property, and equipment, net:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Capitalized software amortization expense | $65,348 | $83,250 | $78,441 |
| Depreciation and amortization expense, excluding capitalized software | 13,346 | 14,910 | 17,565 |
| Total depreciation and amortization expense for technology, property and equipment | $78,694 | $98,160 | $96,006 |
In fiscal years 2025 and 2024, as a result of our decision to discontinue the use of certain capitalized software, we determined that a revision of the useful lives was warranted, and certain capitalized software was fully amortized over its revised remaining useful life. In addition, certain work-in-process capitalized software was impaired since it is no longer probable that the software being developed will be completed, and was reported at the lower of its carrying amount or fair value which was zero.
For the year ended April 30, 2025, the total amount was $1.5 million, which included $0.8 million of accelerated amortization expense and $0.7 million of impairment charges reflected in Restructuring and related charges on our Consolidated Statements of Income (Loss). These charges were recorded in the Research segment.
For the year ended April 2024, the total amount was $20.3 million, which included $15.9 million of accelerated amortization expense reflected in depreciation and amortization in Operating and administrative expenses and $4.4 million of impairment charges reflected in Restructuring and related charges on our Consolidated Statements of Income (Loss). These charges were recorded in the Research and Learning segments as well as Corporate Expenses.
Index
Note 11 –Goodwill and Intangible Assets
Goodwill
The following table summarizes the activity in goodwill by segment as of April 30:
| Research | Learning | Total excluding Held for Sale or Sold segment | Held for Sale or Sold(1) | Total including Held for Sale or Sold segment | |
|---|---|---|---|---|---|
| Balance at April 30, 2023 | $609,729 | $486,025 | $1,095,754 | $108,296 | $1,204,050 |
| Impairment | — | — | — | (108,449) | (108,449) |
| Foreign Translation Adjustment | (2,440) | (1,946) | (4,386) | 153 | (4,233) |
| Balance at April 30, 2024 | 607,289 | 484,079 | 1,091,368 | — | 1,091,368 |
| Acquisition(2) | — | 1,026 | 1,026 | — | 1,026 |
| Foreign Translation Adjustment | 32,145 | (3,034) | 29,111 | — | 29,111 |
| Balance at April 30, 2025 | $639,434 | $482,071 | $1,121,505 | $— | $1,121,505 |
| (1) | The Held for Sale or Sold goodwill balance as of April 30, 2024 includes accumulated pretax noncash goodwill impairments of $318.2 million which reduced the goodwill of all reporting units within the Held for Sale or Sold segment to zero. |
| (2) | Refer to Note 4, “Acquisitions and Divestitures,” for more information related to the acquisition that occurred in the year ended April 30, 2025. |
Annual Impairment Test as of February 1, 2025
For our reporting units within the Research and Learning segments, we performed a qualitative assessment by reporting unit as of February 1, 2025. This assessment included consideration of key factors including macroeconomic conditions, industry and market considerations, financial performance, weighted average cost of capital (WACC), market multiples of current and forward 12-month EBITDA, and other relevant entity and reporting unit-specific events. Based on our qualitative assessment, we determined it was not more likely than not that the fair value of any reporting unit was less than its carrying amount. As such, it was not necessary to perform a quantitative test. There have been no significant events or circumstances affecting the valuation of goodwill subsequent to the qualitative assessment performed as of February 1, 2025.
If the fair value of these reporting units decreases in future periods, we could potentially have an impairment. The future occurrence of a potential indicator of impairment, such as a decrease in expected net earnings, changes in assumptions, adverse equity market conditions, a decline in current market multiples, a decline in our common stock price, a significant adverse change in legal factors or business climates, an adverse action or assessment by a regulator, unanticipated competition, strategic decisions made in response to economic or competitive conditions, or a more-likely-than-not expectation that a reporting unit or a significant portion of a reporting unit will be sold or disposed of, could require an interim assessment for some or all of the reporting units before the next required annual assessment.
Fiscal Year 2024
We recorded a goodwill impairment of $108.4 million in the year ended April 30, 2024. These charges are reflected in Impairment of goodwill on our Consolidated Statements of Income (Loss).
Change in Segment Reporting Structure and Goodwill Impairment
In the three months ended July 31, 2023, we reorganized our segments. Due to this realignment, we reallocated goodwill in the first quarter of fiscal year 2024 to our reporting units on a relative fair value basis.
Index
As a result of this realignment, we were required to test goodwill for impairment immediately before and after the realignment. Since there were no changes to the Research reportable segment, no impairment test of the Research segment goodwill was required.
We estimated the fair value of the reporting units using a weighting of fair values derived from an income and a market approach. Fair value computed by these methods is arrived at using a number of key assumptions including forecasted revenues and related growth rates, forecasted operating cash flows, the discount rate, and the selection of relevant market multiples of comparable publicly-traded companies with similar characteristics to the reporting unit. Under the income approach, we determined the fair value of a reporting unit based on the present value of estimated future cash flows. Cash flow projections are based on our best estimates of forecasted economic and market conditions over the period including growth rates and expected changes in operating cash flows. The discount rate used is based on a weighted average cost of capital adjusted for the relevant risk associated with the characteristics of the business and the projected cash flows. The market approach estimates fair value based on market multiples of current and forward 12-month revenue or EBITDA, as applicable, derived from comparable publicly traded companies with similar operating and investment characteristics as the reporting unit.
Prior to the realignment, the previous reporting units (Academic Publishing, Talent Development, which includes Wiley Edge, and Professional Learning) fair values were above their carrying values. Therefore, there was no indication of impairment. The carrying value of the University Services reporting unit was above its fair value, which resulted in a pretax noncash goodwill impairment of$11.4 million. Such impairment reduced the goodwill of the University Services reporting unit tozero. University Services was adversely impacted by market conditions and headwinds for online degree programs, which led to a decline in projected enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term which adversely impacted forecasted revenue growth and operating cash flows. We also evaluated the recoverability of long-lived assets of the University Services reporting unit and there was no impairment.
After the realignment, the new reporting units (Academic, Professional, and Wiley Edge) fair values were above their carrying values. Therefore, there was no indication of impairment. The carrying value of the CrossKnowledge reporting unit was above its fair value which resulted in a pretax noncash goodwill impairment of$15.3 million. Such impairment reduced the goodwill of the CrossKnowledge reporting unit tozero. CrossKnowledge was adversely impacted by a decline in the demand for its offerings, which resulted in lower sales and a decline in average contract value, that adversely impacted forecasted revenue growth and operating cash flows. We also evaluated the recoverability of long-lived assets of the CrossKnowledge reporting unit and there was no impairment.
Wiley Edge Interim Impairment Test
As a result of signing the Edge Agreement with Inspirit and the decrease in the fair value of the business, which was impacted by a decline in placements, in the third quarter of fiscal year 2024, we tested the goodwill of the Wiley Edge reporting unit for impairment. We concluded that the carrying value of the Wiley Edge reporting unit was above its fair value, which resulted in a pretax noncash goodwill impairment of approximately$81.7 million. Such impairment reduced the goodwill of the Wiley Edge reporting unit tozero. The impairment was due to subsequent changes in the fair value resulting from the continued progression of the selling process, indications of changes in the consideration for the business, and a decline in placements in the third quarter of fiscal year 2024, as well as changes in the carrying amounts of the disposal group. We also evaluated the recoverability of long-lived assets of the Wiley Edge reporting unit and there was no impairment.
Refer to Note 4, “Acquisitions and Divestitures,” for more information.
Annual Impairment Test as of February 1, 2024
For our reporting units within the Research and Learning segments, we performed a qualitative assessment by reporting unit as of February 1, 2024. This assessment included consideration of key factors including macroeconomic conditions, industry and market considerations, financial performance, WACC, market multiples of current and forward 12-month revenue or EBITDA, as applicable, and other relevant entity and reporting unit-specific events. Based on our qualitative assessment, we determined it was not more likely than not that the fair value of any reporting unit was less than its carrying amount. As such, it was not necessary to perform a quantitative test.
Index
Fiscal Year 2023
We recorded a goodwill impairment of $99.8 million in the year ended April 30, 2023. These charges are reflected in Impairment of goodwill on our Consolidated Statements of Income (Loss).
Change in Segment Reporting Structure and Goodwill Impairment
In the three months ended January 31, 2023, we reorganized our segments. Due to this realignment, we reallocated goodwill in the third quarter of fiscal year 2023 to our reporting units on a relative fair value basis.
As a result of this realignment, we were required to test goodwill for impairment immediately before and after the realignment. Since there were no changes to the Research reportable segment, no interim impairment test of the Research segment goodwill was required.
We estimated the fair value of the reporting units using a weighting of fair values derived from an income and a market approach. Fair value computed by these methods is arrived at using a number of key assumptions including forecasted revenues and related growth rates, forecasted operating cash flows, the discount rate, and the selection of relevant market multiples of comparable publicly-traded companies with similar characteristics to the reporting unit. Under the income approach, we determined the fair value of a reporting unit based on the present value of estimated future cash flows. Cash flow projections are based on our best estimates of forecasted economic and market conditions over the period including growth rates and expected changes in operating cash flows. The discount rate used is based on a weighted average cost of capital adjusted for the relevant risk associated with the characteristics of the business and the projected cash flows. The market approach estimates fair value based on market multiples of current and forward 12-month revenue or EBITDA, as applicable, derived from comparable publicly traded companies with similar operating and investment characteristics as the reporting unit.
Prior to the realignment, we concluded that the fair value of the Academic & Professional Learning reporting unit was above its carrying value. Therefore, there was no indication of impairment. The carrying value of the Education Services reporting unit was above its fair value, which resulted in a pretax noncash goodwill impairment of $31.0 million. Education Services was adversely impacted by market conditions and headwinds for online degree programs. This has led to a decline in projected student enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term, which adversely impacted forecasted revenue growth and operating cash flows. This was partially offset by projected growth in talent placements, partially due to expansion into new regions and the addition of new corporate clients, which are forecasted to have a positive impact on revenue growth and operating cash flows. We also evaluated the recoverability of long-lived assets of the Education Services reporting unit and there was no impairment.
After the realignment, we concluded that the fair value of the Academic Publishing, Talent Development and Professional Learning reporting units were above their carrying values. Therefore, there was no indication of impairment. The carrying value of the University Services reporting unit was above its fair value, which resulted in a pretax noncash goodwill impairment of $68.8 million. University Services was adversely impacted by market conditions and headwinds for online degree programs which led to a decline in projected enrollments from existing partners, pricing pressures and revenue share concessions, and a decline in new partner additions over both the short-term and long-term which adversely impacted forecasted revenue growth and operating cash flows. We also evaluated the recoverability of long-lived assets of the University Services reporting unit and there was no impairment.
Index
Intangible Assets
Intangible assets, net as of April 30 were as follows:
| 2025 | 2024 | |||||
|---|---|---|---|---|---|---|
| Cost | AccumulatedAmortization | Net | Cost | AccumulatedAmortization | Net | |
| Intangible assets with definite lives, net(1): | ||||||
| Content and publishing rights | $1,080,115 | $(662,133) | $417,982 | $1,087,601 | $(656,342) | $431,259 |
| Customer relationships | 131,037 | (95,996) | 35,041 | 125,521 | (85,812) | 39,709 |
| Developed technology(2) | 41,195 | (28,789) | 12,406 | 44,880 | (25,358) | 19,522 |
| Brands and trademarks | 30,538 | (25,484) | 5,054 | 31,448 | (25,714) | 5,734 |
| Covenants not to compete | 1,157 | (1,148) | 9 | 1,157 | (1,123) | 34 |
| Total intangible assets with definite lives, net | 1,284,042 | (813,550) | 470,492 | 1,290,607 | (794,349) | 496,258 |
| Intangible assets with indefinite lives: | ||||||
| Brands and trademarks(2) | 37,000 | — | 37,000 | 37,000 | — | 37,000 |
| Publishing rights | 87,552 | — | 87,552 | 82,436 | — | 82,436 |
| Total intangible assets with indefinite lives | 124,552 | — | 124,552 | 119,436 | — | 119,436 |
| Total intangible assets, net | $1,408,594 | $(813,550) | $595,044 | $1,410,043 | $(794,349) | $615,694 |
| (1) | Refer to Note 4, “Acquisitions and Divestitures,” for more information related to the acquisition that occurred in the year ended April 30, 2025. |
| (2) | The developed technology balance as of April 30, 2025 and 2024 is presented net of accumulated impairments and write-offs of $2.8 million. The indefinite-lived brands and trademarks balance as of April 30, 2025 and 2024 is net of accumulated impairments of $93.1 million. |
Based on the current amount of intangible assets subject to amortization and assuming current foreign exchange rates, the estimated amortization expense for the following years are as follows:
| Fiscal Year | Amount |
|---|---|
| 2026 | $51,561 |
| 2027 | 46,767 |
| 2028 | 40,844 |
| 2029 | 36,326 |
| 2030 | 32,523 |
| Thereafter | 262,471 |
| Total | $470,492 |
Annual Indefinite-lived Intangible Impairment Test as of February 1, 2025 and 2024
We also review our indefinite-lived intangible assets for impairment annually, which consists of brands and trademarks and certain acquired publishing rights.
For fiscal years 2025 and 2024, we performed a qualitative assessment for our annual indefinite-lived intangible assets impairment test. This assessment included consideration of key factors including macroeconomic conditions, industry and market considerations, financial performance, WACC, and other relevant entity and reporting unit-specific events. Based on our qualitative assessment, we determined it was not more likely than not that the fair value of any indefinite-lived intangible asset was less than its carrying amount. As such, it was not necessary to perform a quantitative test.
Index
Note 12 –Operating Leases
We have contractual obligations as a lessee with respect to offices, warehouses and distribution centers, automobiles, and office equipment.
We determine if an arrangement is a lease at inception of the contract in accordance with guidance detailed in the lease standard and we perform the lease classification test as of the lease commencement date. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term.
The present value of the lease payments is calculated using an incremental borrowing rate, which was determined based on the rate of interest that we would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. We use an unsecured borrowing rate and risk-adjust that rate to approximate a collateralized rate.
We recognize operating lease expense on a straight-line basis over the term of the lease. Lease payments may be fixed or variable. Only lease payments that are fixed, in-substance fixed or depend on a rate or index are included in determining the lease liability. Variable lease payments include payments made to the lessor for taxes, insurance and maintenance of the leased asset and are recognized as operating costs as incurred.
We apply certain practical expedients allowed by ASC Topic 842, “Leases”. Leases that are more than one year in duration are capitalized and recorded on our Consolidated Statements of Financial Position. Leases with an initial term of 12 months or less are recognized as short term lease operating costs on a straight-line basis over the term. We have also elected to account for the lease and non-lease components as a single component. Some of our leases offer an option to extend the term of such leases. We utilize the reasonably certain threshold criteria in determining which options we will exercise.
For operating leases, the ROU assets and liabilities as of April 30 are presented in our Consolidated Statements of Financial Position as follows:
| 2025 | 2024 | |
|---|---|---|
| Operating lease ROU assets | $66,128 | $69,074 |
| Short-term portion of operating lease liabilities | 18,282 | 18,294 |
| Operating lease liabilities, non-current | $81,482 | $94,386 |
As a result of the Global Restructuring Program, which included the exit of certain leased office space, we recorded restructuring and related charges, which included impairment charges and the acceleration of expense associated with certain operating lease ROU assets. See Note 7, “Restructuring and Related Charges” for more information on this program and the charges incurred.
Our total net lease costs were as follows:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating lease cost | $14,613 | $14,575 | $18,620 |
| Variable lease cost | 833 | 1,096 | 1,326 |
| Short-term lease cost | 455 | 1,059 | 744 |
| Sublease income | (560) | (847) | (770) |
| Total net lease cost(1) | $15,341 | $15,883 | $19,920 |
| (1) | Total net lease cost does not include those costs and sublease income for operating leases we had identified as part of our restructuring programs that would be subleased. The costs and sublease income for those leases are included in Restructuring and related charges on our Consolidated Statements of Income (Loss). See Note 7, “Restructuring and Related Charges” for more information on these programs. |
Index
Other supplemental information includes the following:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Weighted-average remaining contractual lease term (years) | 7 | 7 | 8 |
| Weighted-average discount rate | 6.16% | 6.05% | 5.95% |
| Cash paid for amounts included in the measurement of lease liabilities: | |||
| Operating cash flows from operating leases | $22,209 | $25,852 | $26,919 |
| Operating lease liabilities arising from obtaining ROU assets | $1,646 | $2,199 | $2,686 |
The table below reconciles the undiscounted cash flows for the first five years and total of the remaining years to the operating lease liabilities recorded in the Consolidated Statement of Financial Position as of April 30, 2025:
| Fiscal Year | Operating LeaseLiabilities |
|---|---|
| 2026 | $23,137 |
| 2027 | 18,743 |
| 2028 | 15,235 |
| 2029 | 14,625 |
| 2030 | 14,513 |
| Thereafter | 36,052 |
| Total future undiscounted minimum lease payments | 122,305 |
| Less: Imputed interest | 22,541 |
| Present value of minimum lease payments | 99,764 |
| Less: Current portion | 18,282 |
| Noncurrent portion | $81,482 |
Index
Note 13 –Income Taxes
The provision for income taxes were as follows:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Current provision | |||
| US – Federal | $5,497 | $2,152 | $2,857 |
| International | 50,300 | 49,357 | 48,694 |
| State and local | 1,981 | (337) | 1,797 |
| Total current provision | $57,778 | $51,172 | $53,348 |
| Deferred provision (benefit) | |||
| US – Federal | $3,394 | $(25,026) | $(24,368) |
| International | 1,696 | (4,772) | (8,705) |
| State and local | (4,151) | (8,102) | (4,408) |
| Total deferred provision (benefit) | $939 | $(37,900) | $(37,481) |
| Total provision | $58,717 | $13,272 | $15,867 |
International and United States pretax income (loss) were as follows:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| International | $189,781 | $109,616 | $204,055 |
| United States | (46,903) | (296,663) | (170,955) |
| Total | $142,878 | $(187,047) | $33,100 |
Our effective income tax rate as a percentage of pretax income differed from the US federal statutory rate as shown below:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| US federal statutory rate | 21.0% | 21.0% | 21.0% |
| Impact of foreign operations | 8.8% | (11.7)% | (10.5)% |
| Change in valuation allowance | 14.4% | (14.0)% | (7.4)% |
| State income taxes, net of US federal tax benefit | (1.5)% | 4.6% | (7.2)% |
| Tax credits and related net benefits | (2.7)% | 1.8% | (12.1)% |
| Impairment of goodwill | —% | (10.9)% | 66.7% |
| Return to provision | (1.9)% | 6.1% | (13.7)% |
| Other | 3.0% | (4.0)% | 11.1% |
| Effective income tax rate | 41.1% | (7.1)% | 47.9% |
The Company's effective tax rate for the fiscal year ended April 30, 2025, was primarily driven by the impact of the US valuation allowance, the rates of tax imposed on income earned in foreign jurisdictions, and state taxes.
Index
Accounting for Uncertainty in Income Taxes:
As of April 30, 2025, and April 30, 2024, the total amount of unrecognized tax benefits was $9.8 million and $9.2 million, respectively, of which $0.4 million and $0.2 million represented accruals for interest and penalties recorded as additional tax expense in accordance with our accounting policy. As of April 30, 2025, and April 30, 2024, the total interest and penalties was $0.8 million and $0.6 million, respectively. We recorded net interest expense on reserves for unrecognized and recognized tax benefits of $0.2 million in each of the years ended April 30, 2025, and April 30, 2024. As of April 30, 2025, and April 30, 2024, the total amounts of unrecognized tax benefits that would reduce our income tax provision, if recognized, were approximately $9.8 million and $9.2 million, respectively. We do not expect any significant changes to the unrecognized tax benefits within the next twelve months.
A reconciliation of the unrecognized tax benefits included within the Other long-term liabilities on the Consolidated Statements of Financial Position is as follows:
| For the Years Ended April 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Balance at May 1 | $9,151 | $9,421 |
| Additions for current year tax positions | 1,423 | 1,607 |
| Reductions for prior year tax positions | (337) | (181) |
| Payments and settlements | — | (849) |
| Reductions for lapse of statute of limitations | (440) | (847) |
| Balance at April 30 | $9,797 | $9,151 |
Tax Audits:
We file income tax returns in the US and various states and non-US tax jurisdictions. Our major taxing jurisdictions are the United States, the United Kingdom, and Germany. We are no longer subject to income tax examinations for years prior to fiscal year 2014 in the major jurisdictions in which we are subject to tax.
Deferred Taxes:
Deferred taxes result from temporary differences in the recognition of revenue and expense for tax and financial reporting purposes.
Index
The significant components of deferred tax assets and liabilities as of April 30 were as follows:
| 2025 | 2024 | |
|---|---|---|
| Net operating losses | $11,360 | $22,587 |
| Reserve for sales returns and doubtful accounts | 2,095 | 2,363 |
| Accrued employee compensation | 24,967 | 27,293 |
| Foreign and federal credits | 28,835 | 33,742 |
| Other accrued expenses | 1,009 | 3,822 |
| Retirement and post-employment benefits | 8,282 | 10,203 |
| Operating lease liabilities | 18,308 | 23,095 |
| Interest expense disallowance | 14,919 | 10,676 |
| Impairment | 9,543 | — |
| Other | 415 | — |
| Total gross deferred tax assets | $119,733 | $133,781 |
| Less valuation allowance | (77,309) | (53,498) |
| Total deferred tax assets | $42,424 | $80,283 |
| Prepaid expenses and other assets | $(861) | $(5,352) |
| Unremitted foreign earnings | (2,220) | (3,115) |
| Intangible and fixed assets | (130,077) | (155,862) |
| Right-of-use assets | (10,848) | (12,685) |
| Total deferred tax liabilities | $(144,006) | $(177,014) |
| Net deferred tax liabilities | $(101,582) | $(96,731) |
| Reported As | ||
| Deferred tax assets excluding held-for-sale | 3,563 | 3,147 |
| Deferred tax assets held-for-sale | — | 6,176 |
| Deferred tax assets | $3,563 | $9,323 |
| Deferred tax liabilities excluding held-for-sale | (105,145) | (97,186) |
| Deferred tax liabilities held-for-sale | — | (8,868) |
| Deferred tax liabilities | (105,145) | (106,054) |
| Net deferred tax liabilities | $(101,582) | $(96,731) |
The change in net deferred taxes was primarily due to the decrease in net deferred tax liabilities primarily attributable to a decrease in tax liabilities in the capitalization of research and development (R&D) expenses. In addition, we had a decrease in net deferred tax assets related to an increase in the valuation allowance. In assessing the need for a valuation allowance, we take into account prior earnings history, expected future earnings, reversal of existing taxable temporary differences, carry back and carry forward periods and tax planning strategies that could potentially enhance the likelihood of the realization of a deferred tax asset. Changes to tax laws and statutory tax rates can also have an impact on our valuation allowances. Changes in valuation allowances are included in the Company’s income tax provision in the period of change.
We have provided a $77.3 million valuation allowance as of April 30, 2025. This valuation allowance is increased by approximately $23.8 million from the valuation allowance as of April 30, 2024. In fiscal year 2024, due to temporary differences in the US, our deferred taxes reversed from a net deferred tax liability position to a net deferred tax asset position. Due to losses in the US resulting from impairments, restructuring, and acceleration of amortization expense on capitalized software, we concluded it was more-likely-than-not that all or a portion of our deferred tax asset may not be realized. As a result, we established a valuation allowance of $30.2 million. During fiscal year 2025 we increased this valuation allowance by $26.0 million, because of an increase in the US net deferred tax asset attributable primarily to interest expense disallowance and intangible and fixed assets.
Index
As of April 30, 2025, we have apportioned state net operating loss carryforwards totaling approximately $126 million, with a tax effected value of $7.1 million net of federal benefits. We have foreign net operating loss carryforwards totaling approximately $0.1 million, and federal net operating loss carryforwards totaling $2.4 million, with a tax effected value of $0.5 million. Our state, foreign, and federal NOLs and credits, to the extent they expire, expire in various amounts from 1 year to indefinite.
We intend to repatriate earnings from our non-US subsidiaries, and to the extent we repatriate these funds to the US, we may be required to pay taxes in various US state and local jurisdictions and withholding or similar taxes in applicable non-US jurisdictions in the periods in which such repatriation occurs. As of April 30, 2025, we have recorded a $2.2 million liability related to the estimated taxes that would be incurred upon repatriating certain non-US earnings to the US.
Note 14 –Debt and Available Credit Facilities
Our total debt outstanding as of April 30 consisted of the amounts set forth in the following table:
| 2025 | 2024 | |
|---|---|---|
| Short-term portion of long-term debt (1) | $10,000 | $7,500 |
| Term loan A - Amended and Restated CA(2) | 174,581 | 184,418 |
| Revolving credit facility - Amended and Restated CA | 614,854 | 582,678 |
| Total long-term debt, less current portion | 789,435 | 767,096 |
| Total debt | $799,435 | $774,596 |
| (1) | Relates to our term loan A under the Amended and Restated CA. |
| (2) | Amounts are shown net of unamortized issuance costs of $0.4 million as of April 30, 2025 and $0.6 million as of April 30, 2024. |
The following table summarizes the scheduled annual maturities for the next three years of our long-term debt, including the short-term portion of long-term debt. This schedule represents the principal portion amount of debt outstanding and therefore excludes unamortized issuance costs.
| Fiscal Year | Amount |
|---|---|
| 2026 | $10,000 |
| 2027 | 12,500 |
| 2028 | 777,354 |
| Total | $799,854 |
Amended and Restated CA
On November 30, 2022, we entered into the second amendment to the Third Amended and Restated Credit Agreement (collectively, the Amended and Restated CA). The Amended and Restated CA as of November 30, 2022 provided for senior unsecured credit facilities comprised of the following (i) afive-year revolving credit facility in an aggregate principal amount up to $1.115 billion which matures November 2027, (ii) afive-year term loan A facility consisting of $200 million which matures November 2027, and (iii) $185 million aggregate principal amount revolving credit facility which matured in May 2024.
Index
Under the terms of the Amended and Restated CA, which can be drawn in multiple currencies, we have the option of borrowing at the following floating interest rates depending on the currency borrowed: (i) at a rate based on the US Secured Overnight Financing Rate (SOFR), the Sterling Overnight Index Average Rate (SONIA) or a EURIBOR-based rate, each rate plus an applicable margin ranging from 0.98% to 1.50%, depending on our consolidated net leverage ratio, as defined, or (ii) at the lender’s base rate plus an applicable margin ranging from zero to 0.50%, depending on our consolidated net leverage ratio. With respect to SOFR loans, there is a SOFR adjustment of between 0.10% and 0.25% depending on the duration of the loan. The lender’s base rate is defined as the highest of (i) the US federal funds effective rate plus a 0.50% margin, (ii) the Daily SOFR rate, as defined, plus a 1.00% margin, or (iii) the Bank of America prime lending rate. In addition, we pay a facility fee for the Amended and Restated CA ranging from 0.15% to 0.25% depending on our consolidated net leverage ratio. We also have the option to request an increase in the revolving credit facility by an amount not to exceed $500 million, in minimum increments of $50 million, subject to the approval of the lenders.
The Amended and Restated CA contains certain customary affirmative and negative covenants, including a financial covenant in the form of a consolidated net leverage ratio and consolidated interest coverage ratio, which we were in compliance with as of April 30, 2025.
In the three months ended January 31, 2023, we incurred a loss of $(0.2) million on the write-off of unamortized deferred costs in connection with the second amendment of the Amended and Restated CA which is reflected in Other income (expense), net on our Consolidated Statements of Income (Loss) for the year ended April 30, 2023.
The amortization expense of the costs incurred related to the Amended and Restated CA related to the lender and non-lender fees is recognized over afive-year term for credit commitments that mature in November 2027 and an 18-month term for credit commitments that matured in May 2024. Total amortization expense included in Interest expense on our Consolidated Statements of Income (Loss) is as follows:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Amortization expense | $1,145 | $1,246 | $1,129 |
Lines of Credit
We have other lines of credit aggregating $1.0 million at various interest rates. There wereno outstanding borrowings under these credit lines at April 30, 2025 and 2024.
Our total available lines of credit as of April 30, 2025 were approximately $1,300.6 million which includes the Amended and Restated CA, of which approximately $500.7 million was unused. We had letters of credit of $0.4 million outstanding under the Amended and Restated CA, and the aggregate stated amount outstanding of these letters of credit reduces the total borrowing base available under the Amended and Restated CA.
The weighted average interest rates on total debt outstanding during the years ended April 30, 2025 and 2024 were 6.10% and 5.52%, respectively. As of April 30, 2025 and 2024, the weighted average interest rates for total debt were 5.57% and 6.07%, respectively.
Based on estimates of interest rates currently available to us for loans with similar terms and maturities, the fair value of our debt approximates its carrying value.
Index
Note 15 –Derivative Instruments and Activities
Interest Rate Contracts
As of April 30, 2025, we had total debt outstanding of $799.4 million, net of unamortized issuance costs of $0.4 million. The $799.8 million of debt outstanding are variable rate loans under the Amended and Restated CA. The carrying value of the debt approximates fair value.
As of April 30, 2025 and 2024, the interest rate swap agreements we maintained were designated as fully effective cash flow hedges as defined under ASC Topic 815. As a result, the impact on our Consolidated Statements of Income (Loss) from changes in the fair value of the interest rate swaps was fully offset by changes in the interest expense on the underlying variable rate debt instruments. It is management’s intention that the notional amount of interest rate swaps be less than the variable rate loans outstanding during the life of the derivatives.
As of both April 30, 2025 and 2024, we had interest rate swaps outstanding with a combined notional amount of $500.0 million that were designated as cash flow hedges.
We record the fair value of our interest rate swaps on a recurring basis using Level 2 inputs of quoted prices for similar assets or liabilities in active markets. The fair value of our interest rate swaps designated as cash flow hedges as of April 30 are reflected in our Consolidated Statements of Financial Position as follows:
| Asset (Liability) | Balance Sheet Location | 2025 | 2024 |
|---|---|---|---|
| Current asset portion | Prepaid expenses and other current assets | $197 | $154 |
| Non-current asset portion | Other non-current assets | — | 9,686 |
| Current liability portion | Other accrued liabilities | (118) | — |
| Non-current liability portion | Other long-term liabilities | (3,438) | — |
| Total cash flow hedges | $(3,358) | $9,840 |
The effect of our interest rate swaps on the Consolidated Statements of Comprehensive Income (Loss) and the Consolidated Statements of Income (Loss) for the years ended April 30 are as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Amount of pretax (losses) gains recognized in Other comprehensive income (loss) | $(8,186) | $15,164 | $6,036 |
| Amount of pretax gains reclassified from Accumulated other comprehensive loss into Interest expense | $4,755 | $12,420 | $5,039 |
Based on the amount in Accumulated other comprehensive loss at April 30, 2025, approximately $(0.4) million, net of tax, would be reclassified into Net income in the next twelve months.
Foreign Currency Contracts
We may enter into foreign currency forward contracts to manage our exposure on certain foreign currency denominated assets and liabilities. The foreign currency forward exchange contracts are marked to market through Net foreign exchange transaction (losses) gains on our Consolidated Statements of Income (Loss) and carried at fair value on our Consolidated Statements of Financial Position. Foreign currency denominated assets and liabilities are remeasured at spot rates in effect on the balance sheet date, with the effects of changes in spot rates reported in Net foreign exchange transaction (losses) gains on our Consolidated Statements of Income (Loss).
As of April 30, 2025 and 2024, we did not maintain any open foreign currency forward contracts. In addition, we did not maintain any open foreign currency forward contracts during the years ended April 30, 2025, 2024, and 2023.
Index
Note 16 –Commitment and Contingencies
Legal Proceedings
We are involved in routine litigation in the ordinary course of our business. A provision for litigation is accrued when information available to us indicates that it is probable a liability has been incurred and the amount of loss can be reasonably estimated. Significant judgment may be required to determine both the probability and estimate of loss. When the amount of the loss can only be estimated within a range, the most likely outcome within that range is accrued. If no amount within the range is a better estimate than any other amount, the minimum amount within the range is accrued. When uncertainties exist related to the probable outcome of litigation and/or the amount or range of loss, we do not record a liability, but disclose facts related to the nature of the contingency and possible losses if management considers the information to be material. Reserves for legal defense costs are recognized when incurred. The accruals for loss contingencies and legal costs are reviewed regularly and may be adjusted to reflect updated information on the status of litigation and advice of legal counsel. In the opinion of management, the ultimate resolution of all pending litigation as of April 30, 2025, will not have a material effect upon our consolidated financial condition or results of operations.
Note 17 –Retirement Plans
We have retirement plans that cover substantially all employees. The plans generally provide for employee retirement between the ages 60 and 65, and benefits based on length of service and compensation, as defined.
Defined Benefit Plans
Our Board of Directors approved plan amendments that froze the following retirement plans:
Retirement Plan for the Employees of John Wiley & Sons, Canada was frozen effective December 31, 2015;
Retirement Plan for the Employees of John Wiley & Sons, Ltd., a UK plan was frozen effective April 30, 2015 and;
US Employees’ Retirement Plan, Supplemental Benefit Plan, and Supplemental Executive Retirement Plan, were frozen effective June 30, 2013.
We maintain the Supplemental Executive Retirement Plan for certain officers and senior management which provides for the payment of supplemental retirement benefits after the termination of employment for 10 years, or in a lifetime annuity. Under certain circumstances, including a change of control as defined, the payment of such amounts could be accelerated on a present value basis. Future accrued benefits to this plan have been discontinued as noted above.
The components of net pension expense (income) for the defined benefit plans and the weighted average assumptions were as follows:
| For the Years Ended April 30, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| US | Non-US | US | Non-US | US | Non-US | |
| Service cost | $— | $560 | $— | $532 | $— | $796 |
| Interest cost | 12,133 | 16,603 | 11,654 | 16,069 | 11,242 | 13,389 |
| Expected return on plan assets | (9,610) | (18,449) | (10,372) | (19,443) | (9,924) | (23,134) |
| Amortization of prior service cost | (154) | 66 | (154) | 60 | (154) | 60 |
| Amortization of net actuarial loss | 2,314 | 6,058 | 2,446 | 5,656 | 2,295 | 3,851 |
| Curtailment/settlement (credit) | — | (181) | — | — | — | (1,828) |
| Net pension expense (income) | $4,683 | $4,657 | $3,574 | $2,874 | $3,459 | $(6,866) |
| Discount rate | 5.8% | 5.1% | 5.1% | 4.8% | 4.6% | 3.0% |
| Rate of compensation increase | N/A | 3.0% | N/A | 3.0% | N/A | 3.1% |
| Expected return on plan assets | 5.8% | 6.2% | 5.8% | 6.4% | 5.0% | 5.5% |
Index
In the year ended April 30, 2025, due to the sale of the CrossKnowledge business, there was acurtailment and a settlement credit due to the divestment of the CrossKnowledge Pension Plan of $(0.2) million which is primarily reflected in Other income (expense), net on our Consolidated Statements of Income (Loss).
In the year ended April 30, 2023, because of a reduction in force, there was a curtailment credit of $(0.3) million related to the retirement allowances for employees of CrossKnowledge, a France Pension Plan, which is reflected in Other income (expense), net on our Consolidated Statements of Income (Loss). In addition, in the year ended April 30, 2023 due to the closure of our operations in Russia, there was a curtailment and a settlement credit due to the wind up of the Russia Pension Plan of $(1.5) million which is primarily reflected in Other income (expense), net on our Consolidated Statements of Income (Loss).
The service cost component of net pension expense (income) is reflected in Operating and administrative expenses on our Consolidated Statements of Income (Loss). The other components of net pension expense (income) are reported separately from the service cost component and below Operating income. Such amounts are reflected in Other income (expense), net on our Consolidated Statements of Income (Loss).
The recognized net actuarial loss for each fiscal year is calculated using the “corridor method,” which reflects the amortization of the net loss at the beginning of the fiscal year in excess of 10% of the greater of the market value of plan assets or the projected benefit obligation. The amortization period is based on the average expected life of plan participants for plans with all or almost all inactive participants and frozen plans, and on the average remaining working lifetime of active plan participants for all other plans.
The vested benefit obligation for our defined benefit postretirement plans is the actuarial present value of the vested benefits to which the employee is currently entitled but based on the employee's expected date of separation of retirement.
We recognize the overfunded or underfunded status of defined benefit postretirement plans, measured as the difference between the fair value of plan assets and the projected benefit obligation, on the Consolidated Statements of Financial Position. The change in the funded status of the plan is recognized in Accumulated other comprehensive loss on the Consolidated Statements of Financial Position. Plan assets and obligations are measured at fair value as of our Consolidated Statements of Financial Position date.
The following table sets forth the changes in, and the status of, our defined benefit plans’ assets and benefit obligations:
Index
| 2025 | 2024 | |||
|---|---|---|---|---|
| US | Non-US | US | Non-US | |
| CHANGE IN PLAN ASSETS | ||||
| Fair value of plan assets, beginning of year | $173,569 | $293,168 | $186,607 | $302,055 |
| Actual return on plan assets | 13,312 | (7,426) | (707) | (7,276) |
| Employer contributions | 3,198 | 13,526 | 3,672 | 11,708 |
| Employee contributions | — | — | — | — |
| Settlements | — | (729) | — | — |
| Benefits paid | (15,909) | (14,560) | (16,003) | (12,215) |
| Foreign currency rate changes | — | 18,553 | — | (1,104) |
| Fair value, end of year | $174,170 | $302,532 | $173,569 | $293,168 |
| CHANGE IN PROJECTED BENEFIT OBLIGATION | ||||
| Benefit obligation, beginning of year | $(215,563) | $(324,362) | $(235,888) | $(343,008) |
| Service cost | — | (560) | — | (532) |
| Interest cost | (12,133) | (16,603) | (11,654) | (16,069) |
| Actuarial (losses) gains | (4,760) | 22,520 | 15,976 | 21,258 |
| Benefits paid | 15,909 | 14,560 | 16,003 | 12,215 |
| Foreign currency rate changes | — | (19,984) | — | 2,009 |
| Settlements and other | — | 1,097 | — | (235) |
| Benefit obligation, end of year | $(216,547) | $(323,332) | $(215,563) | $(324,362) |
| Underfunded status, end of year | $(42,377) | $(20,800) | $(41,994) | $(31,194) |
| AMOUNTS RECOGNIZED ON THE STATEMENT OF FINANCIAL POSITION | ||||
| Noncurrent assets | — | 12,885 | — | 2,967 |
| Current pension liability | (2,881) | (1,282) | (3,093) | (1,193) |
| Noncurrent pension liability excluding held-for-sale | (39,496) | (32,403) | (38,901) | (31,931) |
| Noncurrent pension liability held-for-sale | — | — | — | (1,037) |
| Noncurrent pension liability | (39,496) | (32,403) | (38,901) | (32,968) |
| Net amount recognized in statement of financial position | $(42,377) | $(20,800) | $(41,994) | $(31,194) |
| AMOUNTS RECOGNIZED IN ACCUMULATED OTHER COMPREHENSIVE LOSS (BEFORE TAX) CONSIST OF | ||||
| Net actuarial losses | $(75,768) | $(206,945) | $(77,025) | $(196,705) |
| Prior service cost gains (losses) | 1,484 | (992) | 1,638 | (1,224) |
| Total accumulated other comprehensive loss | $(74,284) | $(207,937) | $(75,387) | $(197,929) |
| Change in accumulated other comprehensive loss | $1,103 | $(10,008) | $7,188 | $830 |
| INFORMATION FOR PENSION PLANS WITH AN ACCUMULATED BENEFIT OBLIGATION IN EXCESS OF PLAN ASSETS | ||||
| Accumulated benefit obligation | $216,547 | $34,189 | $215,563 | $34,274 |
| Fair value of plan assets | $174,170 | $511 | $173,569 | $481 |
| INFORMATION FOR PENSION PLANS WITH A PROJECTED BENEFIT OBLIGATION IN EXCESS OF PLAN ASSETS | ||||
| Projected benefit obligation | $216,547 | $34,198 | $215,563 | $34,643 |
| Fair value of plan assets | $174,170 | $511 | $173,569 | $481 |
| WEIGHTED AVERAGE ASSUMPTIONS USED IN DETERMINING ASSETS AND LIABILITIES | ||||
| Discount rate | 5.7% | 5.5% | 5.1% | 4.8% |
| Rate of compensation increase | N/A | 3.0% | N/A | 3.0% |
| Accumulated benefit obligations | $(216,547) | $(315,748) | $(215,563) | $(316,107) |
Index
Actuarial losses in the US plans resulting in an increase to our projected benefit obligation for the year ended April 30, 2025, were primarily due to a change in the discount rate and losses from actual demographic experience being different than expected. Actuarial gains for the non-US plans, resulting in a decrease to our projected benefit obligation for the year ended April 30, 2025, were primarily due to a change in the discount rates.
Actuarial gains in the US resulting in a decrease to our projected benefit obligation for the year ended April 30, 2024 were primarily due to an increase in the discount rate. Actuarial gains for the non-US plans, resulting in a decrease to our projected benefit obligation for the year ended April 30, 2024 were primarily due to increases in the discount rates.
Pension plan assets/investments:
The investment guidelines for the defined benefit pension plans are established based upon an evaluation of market conditions, plan liabilities, cash requirements for benefit payments, and tolerance for risk. Investment guidelines include the use of actively and passively managed securities. The investment objective is to ensure that funds are available to meet the plans’ benefit obligations when they are due. The investment strategy is to invest in high quality and diversified equity and debt securities to achieve our long-term expectation. The plans’ risk management practices provide guidance to the investment managers, including guidelines for asset concentration, credit rating, and liquidity. Asset allocation favors a balanced portfolio, with a global aggregated target allocation of approximately 19% equity securities and 81% fixed income securities and cash. Due to volatility in the market, the target allocation is not always desirable and asset allocations will fluctuate between acceptable ranges of plus or minus 5%. We regularly review the investment allocations and periodically rebalance investments to the target allocations. We categorize our pension assets into three levels based upon the assumptions (inputs) used to price the assets. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:
Level 1: Unadjusted quoted prices in active markets for identical assets.
Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets in active markets or quoted prices for identical assets in inactive markets.
Level 3: Unobservable inputs reflecting assumptions about the inputs used in pricing the asset.
We did not maintain any level 3 assets during the years ended April 30, 2025 and 2024.
Certain of our pension assets are invested in common collective trusts managed and valued by the fund administrator. The fair value of the funds is based on the Net Asset Value (NAV) of the underlying investments owned by the fund less its liabilities based on published daily rate. Certain investments that are measured at fair value using the NAV per share (or its equivalent) practical expedient do not have to be classified in the fair value hierarchy. The fair value amounts presented in the following tables are intended to permit reconciliation of the fair value hierarchy to the amounts presented for the total pension benefit plan assets. For those plan assets measured at NAV, a redemption request can be executed within a 7-day notice. There are no unfunded commitments or redemption restrictions for these funds.
Index
The following tables set forth, by level within the fair value hierarchy, pension plan assets at their fair value as of April 30:
| 2025 · 2024 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Level 1 · Level 2 · NAV · Total · Level 1 · Level 2 · NAV · Total | |||||||||||||||||
| US Plan Assets | |||||||||||||||||
| Global Equity Securities: Limited Partnership | $4,904 | $51,727 | $56,631 | $5,598 | $58,238 | $63,836 | |||||||||||
| Fixed Income Securities: Commingled Trust Funds | 117,539 | 117,539 | 109,733 | 109,733 | |||||||||||||
| Total Assets | $4,904 | $169,266 | $174,170 | $5,598 | $167,971 | $173,569 | |||||||||||
| Non-US Plan Assets | |||||||||||||||||
| Equity securities: | |||||||||||||||||
| US equities | $— | $25,110 | $25,110 | $— | $22,496 | $22,496 | |||||||||||
| Non-US equities | — | 9,530 | 9,530 | — | 9,637 | 9,637 | |||||||||||
| Balanced managed funds | — | 71,629 | 71,629 | — | 60,959 | 60,959 | |||||||||||
| Fixed income securities: Commingled funds | — | 100,740 | 100,740 | — | 125,223 | 125,223 | |||||||||||
| Other: | |||||||||||||||||
| Real estate/other | — | 511 | 511 | — | 480 | 480 | |||||||||||
| Cash and cash equivalents | 12,503 | 82,509 | 95,012 | 1,328 | 73,045 | 74,373 | |||||||||||
| Total Non-US plan assets | $12,503 | $290,029 | $— | $302,532 | $1,328 | $291,840 | $— | $293,168 | |||||||||
| Total plan assets | $12,503 | $294,933 | $169,266 | $476,702 | $1,328 | $297,438 | $167,971 | $466,737 | |||||||||
Expected employer contributions to the defined benefit pension plans in the year ended April 30, 2026 will be approximately $4.8 million, including $1.8 million of minimum amounts required for our non-US plans. From time to time, we may elect to make voluntary contributions to our defined benefit plans to improve their funded status.
Benefit payments to retirees from all defined benefit plans are expected to be the following in the fiscal year indicated:
| Fiscal Year | US | Non-US | Total |
|---|---|---|---|
| 2026 | $15,943 | $13,773 | $29,716 |
| 2027 | 15,880 | 14,497 | 30,377 |
| 2028 | 15,865 | 14,741 | 30,606 |
| 2029 | 15,886 | 15,879 | 31,765 |
| 2030 | 15,624 | 16,817 | 32,441 |
| 2031–2035 | 77,327 | 97,312 | 174,639 |
| Total | $156,525 | $173,019 | $329,544 |
Index
Retiree Health Benefits
We provide contributory life insurance and health care benefits, subject to certain dollar limitations, for substantially all of our eligible retired US employees. The retiree health benefit is no longer available for any employee who retires after December 31, 2017. The cost of such benefits is expensed over the years the employee renders service and is not funded in advance. The accumulated post-retirement benefit obligation recognized on the Consolidated Statements of Financial Position as of both April 30, 2025 and 2024 was $0.6 million. Annual credits for these plans were $(0.1) million for each of the years ended April 30, 2025, 2024, and 2023 and are reflected in Operating and administrative expenses on our Consolidated Statements of Income (Loss).
Defined Contribution Savings Plans
We have defined contribution savings plans. Our contribution is based on employee contributions and the level of our match. We may make discretionary contributions to all employees as a group. The expense recorded for these plans was approximately $22.8 million, $27.0 million, and $30.7 million in the years ended April 30, 2025, 2024, and 2023, respectively, and is reflected in Operating and administrative expenses on our Consolidated Statements of Income (Loss).
Note 18 –Stock-Based Compensation
The Company provides stock-based compensation to its employees and non-employee directors, which may include restricted stock units (RSU), PSU, and stock options (collectively, stock-based awards). All equity compensation plans have been approved by shareholders. On September 29, 2022, the Company’s shareholders approved the 2022 Omnibus Stock and Long-Term Incentive Plan (the 2022 Plan), which replaced, with respect to new award grants, our 2014 Key Employee Stock Plan and 2018 Director Stock Plan (the Prior Plans) that were previously in effect. Following the approval of the 2022 Plan, no further awards were available to be issued under the Prior Plans, but awards outstanding under the Prior Plans as of that date remain outstanding in accordance with their terms. A total number of 6.2 million shares of our Class A stock was authorized under the 2022 Plan. In addition, any outstanding awards cancelled from the Prior Plans are added to the shares available under the 2022 Plan. As of April 30, 2025, there were approximately 5.3 million securities remaining that are available for future issuance under the 2022 Plan. We issue treasury shares to fund awards issued under the 2022 Plan.
Stock Option Activity
Under the terms of our stock option plan, the exercise price of stock options granted may not be less than 100% of the fair market value of the stock at the date of grant. Options are exercisable over a maximum period often years from the date of grant. For the options granted in the years ended April 30, 2024 and 2023, such options generally vest 10%,20%,30%, and 40% on April 30, or on each anniversary date after the award is granted. There were no options granted in the year ended April 30, 2025.
The following table provides the estimated weighted average fair value for options granted during the years ended April 30 using the Black-Scholes option-pricing model, and the significant weighted average assumptions used in their determination:
| 2024 | 2023 | |
|---|---|---|
| Weighted average fair value of options on grant date | $6.47 | $9.24 |
| Weighted average assumptions: | ||
| Expected life of options (years) | 6.3 | 5.9 |
| Risk-free interest rate | 4.6% | 2.0% |
| Expected volatility | 34.0% | 32.4% |
| Expected dividend yield | 4.6% | 3.4% |
| Fair value of common stock on grant date | $30.37 | $41.30 |
| Exercise price of stock option grant | $34.86 | $41.30 |
Index
As of April 30, 2025, there was $0.5 million of unrecognized share-based compensation cost related to options, which is expected to be recognized over a period up to 3 years, or 2.0 years on a weighted average basis.
The following table summarizes the activity and status of our stock option plans during the year ended April 30, 2025:
| Numberof Options(in 000’s) | WeightedAverageExercisePrice | WeightedAverageRemainingTerm(in years) | AggregateIntrinsicValue (in millions) | |
|---|---|---|---|---|
| Outstanding at beginning of year | 375 | $48.74 | ||
| Granted | — | $— | ||
| Exercised | (7) | $35.69 | ||
| Expired or forfeited | (118) | $53.50 | ||
| Outstanding at end of year | 250 | $46.87 | 7.4 | $1.2 |
| Exercisable at end of year | 143 | $55.28 | 6.7 | $0.3 |
| Vested and expected to vest in the future at April 30 | 247 | $46.98 | 7.4 | $1.2 |
The intrinsic value is the difference between our common stock price and the option grant price. The total intrinsic value of options exercised during the years ended April 30, 2025 and 2023 was $0.1 million, and $0.1 million, respectively. There wereno options exercised during the year ended April 30, 2024.
The total grant date fair value of stock options vested during the years ended April 30, 2025, 2024, and 2023 was $0.6 million, $0.9 million, and $0.5 million, respectively.
The following table summarizes information about stock options outstanding and exercisable at April 30, 2025:
| Options Outstanding · Options Exercisable | |||||
|---|---|---|---|---|---|
| Range of Exercise Prices | Numberof Options(in 000’s) | Weighted AverageRemainingTerm(in years) | WeightedAverageExercisePrice | Numberof Options(in 000’s) | WeightedAverageExercisePrice |
| $32.68 to $36.60 | 137 | 8.5 | $34.91 | 37 | $34.94 |
| $45.99 to $63.07 | 113 | 6.1 | $61.37 | 106 | $62.39 |
| Total/average | 250 | 7.4 | $46.87 | 143 | $55.28 |
Performance-Based and Other Restricted Stock Activity
Under the terms of our long-term incentive plans, PSU are payable in restricted shares of our Class A Common Stock upon the achievement of certain three-year or less financial performance-based targets. During each three-year period or less, we adjust compensation expense based upon our best estimate of expected performance. Restricted performance share units vest 100% on June 30 following the end of thethree-year performance cycle.
We may also grant individual restricted unit awards payable in restricted shares of our Class A Common Stock to key employees in connection with their employment. Restricted shares generally vest ratably 25% per year.
Under certain circumstances relating to a change of control or termination, as defined, the restrictions would lapse and shares would vest earlier.
Index
Activity for performance-based and other restricted stock awards during the years ended April 30, was as follows (shares in thousands):
| 2025 · 2024 · 2023 | ||||
|---|---|---|---|---|
| RestrictedShares | WeightedAverageGrant DateValue | RestrictedShares | RestrictedShares | |
| Nonvested shares at beginning of year | 1,203 | $37.07 | 1,073 | 1,274 |
| Granted | 735 | $43.06 | 1,089 | 540 |
| Change in shares due to performance | 71 | $39.83 | 54 | (44) |
| Vested and issued | (448) | $41.28 | (660) | (544) |
| Forfeited | (345) | $39.84 | (353) | (153) |
| Nonvested shares at end of year | 1,216 | $38.51 | 1,203 | 1,073 |
We recognized stock-based compensation expense (including stock options) primarily in Operating and administrative expenses on the Consolidated Statements of Income (Loss), on a pretax basis, as follows:
| For the Years Ended April 30, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Stock-based compensation expense | $22,222 | $24,982 | $26,504 |
As of April 30, 2025, there was $27.2 million of unrecognized share-based compensation cost related to performance-based and other restricted stock awards, which is expected to be recognized over a period up to 4 years, or 2.3 years on a weighted average basis.
Compensation expense for restricted stock awards is measured using the closing market price of our Class A Common Stock at the date of grant. The total grant date value of shares vested during the years ended April 30 was as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Grant date value of shares vested | $18,504 | $29,874 | $25,705 |
President and CEO New Hire Equity Awards
On July 8, 2024, the Company named Mr. Matthew Kissner President and CEO and entered into an employment agreement (Employment Agreement) with him. Mr. Kissner had served as the Company’s interim President and CEO since October 10, 2023. Under the Employment Agreement, Mr. Kissner will be eligible to participate in the Company’s Executive Long-Term Incentive Plan (ELTIP), with a target long-term incentive equal to $3.0 million.
Sixty percent of the ELTIP value will be delivered in the form of target performance share units andforty percent in restricted share units. The grant date fair value for the restricted share units was$46.65 per share and included 27,192 restricted share units, which vest 25% each year starting on April 30, 2025 to April 30, 2028. The grant date fair value for the performance share units was$46.65 per share and included 40,789 performance share units, which vest 100% on June 30, 2027. Awards are subject to forfeiture in the case of voluntary termination prior to vesting, and continued vesting in the case of earlier termination of employment without cause or due to constructive discharge. All other terms and conditions are the same as for other executives, as outlined in the ELTIP grant agreements.
Index
Director Stock Awards
On September 29, 2022, the Company’s shareholders approved the 2022 Plan, which replaced, with respect to new award grants, the 2018 Director Stock Plan (the 2018 Plan) that was previously in effect. Under the terms of the 2022 Plan, each nonemployee director is eligible to receive an annual award of restricted shares of our Class A Common Stock equal in value to 100% of the annual director stock retainer fee, based on the stock price at the close of the New York Stock Exchange on the date of grant. Such restricted shares will vest on the earliest of (i) the day before the next annual meeting of stockholders following the grant, (ii) the nonemployee director’s death or disability (as determined by the Governance Committee of the Board of Directors (Governance Committee)), or (iii) a change in control (as defined in the 2022 Plan). The granted shares may not be sold or transferred during the time the nonemployee director remains a director.
There were 23,940,25,744, and 30,706 restricted shares awarded under the 2022 Plan, or the 2018 Plan, as the case may be, for the years ended April 30, 2025, 2024, and 2023, respectively. In addition, pursuant to the John Wiley & Sons, Inc. Deferred Compensation Plan for Directors’ 2005 & After Compensation, as amended through September 20, 2022 (Deferred Compensation Plan), each nonemployee director has the option of receiving all or part of the annual cash retainer in the form of deferred stock and receive dividends in the form of deferred stock. The annual cash retainers deferred as stock and the dividends received in the form of deferred stock, all pursuant to the Deferred Compensation Plan, are nominal for the years ended April 30, 2025, 2024, and 2023.
Note 19 –Capital Stock and Changes in Capital Accounts
Wiley has two classes of common stock, Class A and Class B. Each share of our Class B Common Stock is convertible intoone share of Class A Common Stock. The holders of Class A stock are entitled to elect 30% of the entire Board of Directors and the holders of Class B stock are entitled to elect the remainder. On all other matters, each share of Class A stock is entitled to one tenth of one vote, and each share of Class B stock is entitled toone vote.
Share Repurchases
During the year ended April 30, 2020, our Board of Directors approved a share repurchase program of $200 million of Class A or B Common Stock. As of April 30, 2025, we had authorization from our Board of Directors to purchase up to $57.4 million that was remaining under this program.
The following table summarizes the share repurchases of Class A and B Common Stock during the years ended April 30 (shares in thousands):
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Shares repurchased – Class A | 1,186 | 1,294 | 831 |
| Shares repurchased – Class B | 173 | 3 | 1 |
| Average price – Class A and Class B | $44.16 | $34.71 | $42.07 |
For the year ended April 30, 2025, the average price per share excludes excise taxes payable on share repurchases and may differ from the share repurchases reflected in Purchases of treasury shares in our Consolidated Statements of Cash Flows.
Dividends
We declared and paid quarterly cash dividends on our Class A and Class B Common Stock for a total of$76.1 million,$77.0 million, and$77.3 million during the years ended April 30, 2025, 2024, and 2023, respectively.
Index
Changes in Common Stock
The following is a summary of changes during the years ended April 30, in shares of our common stock and common stock in treasury (shares in thousands).
| Changes in Class A Common Stock: | 2025 | 2024 | 2023 |
|---|---|---|---|
| Number of shares, beginning of year | 70,259 | 70,231 | 70,226 |
| Common stock class conversions | 53 | 28 | 5 |
| Number of shares issued, end of year | 70,312 | 70,259 | 70,231 |
| Changes in Class A Common Stock in treasury: | |||
| Number of shares held, beginning of year | 24,828 | 23,983 | 23,515 |
| Restricted shares issued under stock-based compensation plans | (448) | (662) | (544) |
| Impact of tax withholding on stock-based compensation and other | 121 | 213 | 181 |
| Purchases of treasury shares | 1,186 | 1,294 | 831 |
| Number of shares held, end of year | 25,687 | 24,828 | 23,983 |
| Number of Class A Common Stock outstanding, end of year | 44,625 | 45,431 | 46,248 |
| Changes in Class B Common Stock: | 2025 | 2024 | 2023 |
|---|---|---|---|
| Number of shares, beginning of year | 12,923 | 12,951 | 12,956 |
| Common stock class conversions | (53) | (28) | (5) |
| Number of shares issued, end of year | 12,870 | 12,923 | 12,951 |
| Changes in Class B Common Stock in treasury: | |||
| Number of shares held, beginning of year | 3,928 | 3,925 | 3,924 |
| Purchases of treasury shares | 173 | 3 | 1 |
| Number of shares held, end of year | 4,101 | 3,928 | 3,925 |
| Number of Class B Common Stock outstanding, end of year | 8,769 | 8,995 | 9,026 |
Index
Note 20 –Segment Information
We report our segment information in accordance with the provisions of FASB ASC Topic 280, “Segment Reporting.” We determine our operating and reportable segments based on how our CODM evaluates our business performance, manages the operations, makes operating decisions, and allocates resources.
Our segment reporting structure consists ofthree operating and reportable segments, which are listed below, as well as a Corporate expense category, which includes certain costs that are not allocated to the reportable segments:
Research
Learning
Held for Sale or Sold
Our President and Chief Executive Officer is the Company’s CODM. The performance metric used by our CODM to evaluate performance of our reportable segments is Adjusted Operating Income. The CODM uses Adjusted Operating Income during the annual budgeting process and evaluates budget and forecast-to-actual variances on a monthly basis to make decisions about the allocation of resources to our segments.
Our significant expense categories that are included within Adjusted Operating Income include cost of sales, direct expenses, allocated expenses from our Corporate expense category, and amortization of intangible assets. The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
The following tables present a summary of our Adjusted Operating Income (Loss) by segment, and the reconciliation to Income (Loss) before taxes for the years ended April 30:
| 2025 | ||||
|---|---|---|---|---|
| Research | Learning | Held for Sale or Sold | Total | |
| Revenue | $1,075,459 | $584,768 | $17,382 | $1,677,609 |
| Cost of sales | 278,867 | 144,758 | 7,755 | 431,380 |
| Direct expenses | 336,484 | 142,204 | 10,365 | 489,053 |
| Allocated Corporate expenses | 160,959 | 114,703 | 2,840 | 278,502 |
| Amortization of intangible assets | 43,569 | 8,253 | — | 51,822 |
| Adjusted Operating Income (Loss) by segment | $255,580 | $174,850 | $(3,578) | $426,852 |
| Reconciliation of Adjusted Operating Income by segment to Income before taxes | ||||
| Corporate expenses(1) | (179,882) | |||
| Restructuring and related charges(2) | (25,561) | |||
| Interest expense | (52,547) | |||
| Net foreign exchange transaction losses | (8,142) | |||
| Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | (23,340) | |||
| Other income, net | 5,498 | |||
| Income before taxes | $142,878 | |||
Index
| 2024 | ||||
|---|---|---|---|---|
| Research | Learning | Held for Sale or Sold | Total | |
| Revenue | $1,042,705 | $574,739 | $255,543 | $1,872,987 |
| Cost of sales | 281,109 | 145,054 | 153,559 | 579,722 |
| Direct expenses | 323,392 | 145,514 | 48,127 | 517,033 |
| Allocated Corporate expenses | 155,495 | 132,394 | 23,142 | 311,031 |
| Amortization of intangible assets | 44,946 | 9,044 | 2,004 | 55,994 |
| Adjusted Operating Income by segment | $237,763 | $142,733 | $28,711 | $409,207 |
| Reconciliation of Adjusted Operating Income by segment to Loss before taxes | ||||
| Corporate expenses(1) | (185,456) | |||
| Impairment of goodwill(2) | (108,449) | |||
| Restructuring and related charges(2) | (63,041) | |||
| Interest expense | (49,003) | |||
| Net foreign exchange transaction losses | (2,959) | |||
| Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale | (183,389) | |||
| Other expense, net | (3,957) | |||
| Loss before taxes | $(187,047) | |||
| 2023 | ||||
|---|---|---|---|---|
| Research | Learning | Held for Sale or Sold | Total | |
| Revenue | $1,080,311 | $546,395 | $393,194 | $2,019,900 |
| Cost of sales | 286,361 | 148,925 | 257,255 | 692,541 |
| Direct expenses | 312,383 | 157,694 | 71,310 | 541,387 |
| Allocated Corporate expenses | 151,348 | 130,654 | 38,534 | 320,536 |
| Amortization of intangible assets | 46,235 | 9,022 | 24,909 | 80,166 |
| Adjusted Operating Income by segment | $283,984 | $100,100 | $1,186 | $385,270 |
| Reconciliation of Adjusted Operating Income by segment to Income before taxes | ||||
| Corporate expenses(1) | (171,926) | |||
| Impairment of goodwill(2) | (99,800) | |||
| Restructuring and related charges(2) | (49,389) | |||
| Interest expense | (37,745) | |||
| Net foreign exchange transaction gains | 894 | |||
| Net gain on sale of businesses and assets | 10,177 | |||
| Other income, net | 3,884 | |||
| Legal settlement(3) | (3,671) | |||
| Accelerated amortization of an intangible asset(4) | (4,594) | |||
| Income before taxes | $33,100 | |||
Index
| (1) | Corporate expenses include certain costs that are not allocated to the reportable segments. |
| (2) | See Note 7, “Restructuring and Related Charges” and Note 11, “Goodwill and Intangible Assets” for more information of these charges by segment. |
| (3) | In the three months ended January 31, 2023, we settled a litigation matter related to consideration for a previous acquisition for $3.7 million which is included in Corporate Operating and administrative expenses. |
| (4) | We discontinued use of the mthree trademark that resulted in a change in the useful life and accelerated amortization expense of 4.6 million in the three months ended July 31, 2022. This amortization expense was an adjustment to the Held for Sale or Sold Adjusted operating income. In addition, it was included in Depreciation and amortization in the table below. |
See Note 3, “Revenue Recognition, Contracts with Customers,” for revenue from contracts with customers disaggregated by segment and product type for the years ended April 30, 2025, 2024, and 2023.
Depreciation and amortization expense for the years ended April 30 were as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Research | $89,302 | $93,422 | $93,008 |
| Learning | 43,900 | 57,696 | 57,698 |
| Held for Sale or Sold(1) | — | 3,437 | 46,085 |
| Total depreciation and amortization | $133,202 | $154,555 | $196,791 |
| Corporate depreciation and amortization | 13,924 | 22,434 | 16,462 |
| Total depreciation and amortization | $147,126 | $176,989 | $213,253 |
| (1) | We ceased to record depreciation and amortization of long-lived assets for these businesses as of the date the assets were classified as held-for-sale. |
Revenue for the years ended April 30 from external customers based on the location of the customer were as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| United States | $729,833 | $881,795 | $995,918 |
| China | 141,239 | 120,213 | 150,939 |
| United Kingdom | 118,328 | 165,457 | 150,601 |
| Japan | 83,152 | 84,846 | 89,084 |
| Australia | 75,102 | 74,986 | 79,802 |
| Other countries | 529,955 | 545,690 | 553,556 |
| Total | $1,677,609 | $1,872,987 | $2,019,900 |
Total long-lived assets, consisting of technology, property and equipment, net and operating lease ROU assets by geographical area as of April 30 were as follows:
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| United States | $185,610 | $213,192 | $275,229 |
| United Kingdom | 25,315 | 27,584 | 34,748 |
| Other countries | 17,328 | 20,736 | 28,369 |
| Total | $228,253 | $261,512 | $338,346 |
Our CODM reviews our financial position at a consolidated level and does not review assets by segment to evaluate segment performance or allocate resources. As such, assets by segment are not disclosed.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.